February 1, 2017 Name: Robert L. Barbieri, M.D. Address: 1 Greenbough Lane, Wellesley, MA 02482 Place of Birth: New York, New York Education: 1973 BA Yale University (summa cum laude) 1977 MD Harvard Medical School (magna cum laude) Postdoctoral Training:

Internship and Residencies: 1977-1978 Intern in Internal Medicine, Peter Bent Brigham Hospital 1978-1979 Junior Resident in Internal Medicine, Peter Bent Brigham

Hospital 1979-1980 Senior Resident in Internal Medicine, Peter Bent Brigham

Hospital 1980-1981 Junior Resident in Obstetrics and Gynecology, Brigham and

Women’s Hospital 1982-1983 Senior Resident in Obstetrics and Gynecology, Brigham and

Women's Hospital 1983-1984 Chief Resident in Obstetrics and Gynecology, Brigham and

Women's Hospital Clinical and Research Fellowships:

1981-1982 Clinical and Research Fellow in Medicine, Massachusetts General Hospital

1984-1986 Fellow in Reproductive Endocrinology, Brigham and Women's Hospital

Licensure and Certification:

1980 Massachusetts License Registration No. 48484 1990-1994 New York State License No. 181331

1982 American Board of Internal Medicine, Certificate No. 88721 1983 American Board of Endocrinology and Metabolism, Certificate

No. 88721 1987 American Board of Obstetrics and Gynecology, Certificate

No. 23577 (Annual Maintenance of Certification) 1988 American Board of Obstetrics and Gynecology, Subspecialty

Certification in Reproductive Endocrinology, Certificate No. 23577RE (Annual Maintenance of Certification)

Barbieri C.V. 2

Academic Appointments:

1977-1980 Clinical Fellow in Medicine, Harvard Medical School 1980-1981 Clinical Fellow in Obstetrics and Gynecology, Harvard

Medical School 1981-1982 Research Fellow in Medicine, Harvard Medical School 1982-1984 Clinical Fellow in Obstetrics and Gynecology, Harvard

Medical School 1984-1986 Assistant Professor of Obstetrics and Gynecology, Harvard

Medical School 1986-1987 Associate Professor of Obstetrics and Gynecology, Harvard

Medical School 1987-1990 Associate Professor of Obstetrics, Gynecology and

Reproductive Biology, Harvard Medical School 1990-1993 Professor and Chairman of Obstetrics and Gynecology, State

University of New York at Stony Brook 1993- Kate Macy Ladd Professor of Obstetrics, Gynecology and

Reproductive Biology, Harvard Medical School. Hospital Appointments:

1984-1990 Associate Obstetrician-Gynecologist, Brigham and Women's Hospital

1990-1993 Chief of Obstetrics and Gynecology, University Hospital, State of New York at Stony Brook

1992-1993 Vice President, Medical Staff, University Hospital, Stony Brook, New York

1993- Chief of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA.

Awards and Honors: 1972 Phi Beta Kappa 1977 Soma Weiss Award, Harvard Medical School

1977 Harold Lamport Research Award, Harvard Medical School 1977 Boston Obstetrical Society Research Award

1984 Ortho Research Fellowship of the American College of Obstetricians and Gynecologists

1985 ACOG District I Prize Paper 1987 Commonwealth Fund Medical Fellowship Mentor 1988 Berlex Foundation Scholar

1988 Co-recipient American Fertility Society Associate Members Prize Paper at Annual Meeting

2002 Endometriosis Association Media Award 2015 Gold Award, Best Commentary, American Society of

Healthcare Publication Editors

3

Memberships in Professional Societies:

1983- The American College of Obstetricians and Gynecologists 1991- The American College of Physicians 1977- American Fertility Society 1982- Endocrine Society 1986- Society for the Study of Reproduction 1986- Society for Gynecologic Investigation 1989- Society of Reproductive Endocrinologists 1989- American Association of Gynecologic Laparoscopists 1991- New York Obstetrical Society 1992- American Gynecological and Obstetrical Society 1993- Boston Obstetrical Society 1994-1996 Treasurer, Boston Fertility Society 1995-1996 President, Boston Fertility Society National Service:

1989-1990 Board of Directors, Representing Associate Members, American Fertility Society

1991-1996 National Institutes of Health, Reproductive Biology Initial Review Group

1993-1996 Chairman, National Institutes of Health, Reproductive Biology, Initial Review Group

1992-1995 Examiner, American Board of Obstetrics and Gynecology 1993-2003 Board of Directors, APGO Medical Education Foundation 1994-1995 Program Chairman, Society for Gynecologic Investigation,

42nd Annual Meeting 1994-1996 Steering Committee APGO-Wyeth Executive Management

Courses 1994-1997 Examiner, Reproductive Endocrinology Subspecialty

Certification Exam, American Board of Obstetrics and Gynecology

1994-2003 AAMC, Council of Academic Societies 1995-2000 United States Pharmacopeia Convention, Expert Advisory

Panel on Endocrinology 1995-1999 Board of Directors, American Society of Reproductive

Medicine 1996-2000 NIH Advisory Committee - Nurses Health Study 1997-2000 President, APGO Medical Education Foundation 1998 NIH, Biological and Physiological Sciences, Ad Hoc Initial

Review Group 1999 Chairman NIH, Reproductive Biology, ZRG, Initial Review

Group

Barbieri C.V. 4

National Service (continued):

1999-2001 Co-Chairman, Prolog Writing Group, Office Management American College of Obstetricians and Gynecologists

2000-2001 President Elect, Association of Professors of Gynecology and Obstetrics

2001-2002 President, Association of Professors of Gynecology and Obstetrics

2002-2003 Past President, Association of Professors of Gynecology and Obstetrics

2002-2005 Vice Chair, Massachusetts Section, American College of Obstetricians and Gynecologists 2003 Chairman, NIH, Reproductive Biology ZRG1 Initial Review Group 2003 Chairman, NIH, Contraceptive Clinical Trials Network, ZHD1, Initial Review Group 2005-2008 Chairman, Massachusetts Section, American College of

Obstetricians and Gynecologists 2008 Scientific Chair, Annual District I Meeting, American College

of Obstetricians and Gynecologists 2008-2009 Chair, Induction Task Force, Massachusetts Department of

Public Health, Betsy Lehman Center 2009 Co-Chair, Third Regional Scientific Workshop

“Reproductive to Middle Years”. NIH Office of Research on Women’s Health

5

Editorial Boards:

1987 Associate Editor, Current Problems in Obstetrics, Gynecology and Fertility

1987-1996 Editor, Current Problems in Obstetrics, Gynecology and Fertility

1990-1996 Editorial Board, Fertility and Sterility 1992-2004 Editorial Board, Gynecologic and Obstetric Investigation 1992-1996 Editorial Board, Journal of Clinical Endocrinology and

Metabolism 1993-2000 Editorial Board, Journal of Gynecologic Techniques 1994-2000 Associate Editor, Journal of Gynecologic Techniques 1994-1999 Editorial Board, Reproductive Medicine Review 1996-2004 Editorial Advisory Board, Primary Psychiatry 1996- Editorial Board, Update, American College of Obstetricians

and Gynecologists 1999-2004 Editorial Board, Journal of Clinical Endocrinology and Metabolism

1999- Editor in Chief, UpToDate, Obstetrics and Gynecology 2001- Editor in Chief, OBG Management

2005-2009 Editor, Journal of Clinical Endocrinology and Metabolism

2007-2012 Ad Hoc Editorial Board, S.R.M. Sexuality, Reproduction and Menopause

2015- Editorial Board, New England Journal of Medicine, Journal Watch, Women’s Health

Ad Hoc Editor: Journal of Clinical Endocrinology and Metabolism New England Journal of Medicine American Journal of Obstetrics and Gynecology Journal of Clinical Investigation Obstetrics and Gynecology Journal of the American Medical Association Major Research Interests:

1. Reproductive Endocrinology with focus on folliculogenesis and steroidogenesis

2. Growth factors in reproductive tissues 3. Maternal-fetal endocrinology

Barbieri C.V. 6

Research Funding Information (Completed) 1984-1986 NIH, HD-18292 PI: Robert Barbieri, MD Effect of Insulin and IGFs on Ovarian Steroidogenesis 1984-1986 ACOG-Ortho PI: Robert Barbieri, MD Research Award Effect of Insulin and IGFs on Ovarian Steroidogenesis 1986-1987 William Randolph Hearst PI: Robert Barbieri, MD Research Award Effect of Cigarette Smoking on Fetal Lung Maturation 1986-1988 American Hoechst PI: Robert Barbieri, MD Gestrinone in the Treatment of Endometriosis 1986-1988 Council for Tobacco Research PI: Robert Barbieri, MD Effects of Components of Cigarette Smoke on Steroid Production, Metabolism, and Action 1987-1988 Berlex Foundation PI: Robert Barbieri, MD Research Award Hyperandrogenism and Insulin Resistance in Women 1987-1991 NIH, HD-23536 PI: Rose Frisch, PhD Co-PI: Robert Barbieri, MD MRI, Body Fat and Menstrual Function in Women 1987-1993 NIH, HD-24563 PI: Robert Barbieri, MD Hyperandrogenism and Insulin Resistance in Women 1988-1990 Centocor PI: Robert Barbieri, MD CA-125 in the Diagnosis of Endometriosis 1989-1990 Syntex, Inc PI: Robert Barbieri, MD Effects of Nafarelin on Bone Metabolism 1989-1990 NIH PI: Frank Speizer, MD Co-PI: Robert Barbieri, MD Biochemical Markers in the Nurses Health Study Cohort 1989-1990 NIH PI: James Taylor, PhD Co-PI: Robert Barbieri, MD Biomedical Markers of Disease in a Geriatric Cohort

7

Research Funding Information Past (continued): 1992-1997 NIH, HD-30428 PI: Janet Andersen Collaborator: Robert Barbieri, MD Steroid Regulation of Connexin43 in Myomas 1995-1996 Mass Dept. Public Health PI: Susan Hankinson, DSc Collaborator: Robert Barbieri, MD

Utility of a Single Premenopausal Blood Sample to Predict Breast Cancer Risk

1994-1999 NIH, MO1-RR02635 PI: Richard Nesson, MD Co-PI: Robert Barbieri, MD General Clinical Research Center 1995-2000 NIH-HD-U01-33173 PI: Joseph Hill, MD Co-PI: Robert Barbieri, MD Reproductive Medicine Network 1995-2000 NIH MH/AG 50013 PI: Bernard Harlow, PhD Co-PI: Robert Barbieri, MD Hypogonadism and Depression 1996-2002 NIH-U54HD-29164 PI: William Crowley, MD KI: Robert Barbieri, MD National Program for Infertility Research at Massachusetts General Hospital 1997-1998 Wyeth Ayerst PI: Robert Barbieri, MD CoPI: Elizabeth Ginsburg, MD Premarin Grant-In-Aid 1994-2003 NIH, HD-32153 PI: Daniel Cramer, MD, ScD Co-PI: Robert Barbieri, MD Epidemiologic and Biologic Predictors of IVF Success 1999-2009 NIH-CA49449-08 PI: Susan Hankinson, ScD CoPI: Robert Barbieri, MD Biochemical Markers in the Nurses’ Health Study Cohort

Barbieri C.V. 8

Research Funding Information Past (continued): 2006-2008 NIH-CA1191391 PI: Shelley Tworoger CoPI: Robert Barbieri, MD The Role of Prolactin in the Etiology of Postmenopausal Breast Cancer 2006-2010 NIH-HD052473 PI: Stacey Missmer, ScD CoPI: Robert Barbieri, MD Endogenous Hormones and Risk of Endometriosis 2009-2011 R21 HD059955-01 PI: Francine Grodstein NIH-NICHD 2% CoPI: Robert Barbieri, MD

Long Term Follow-Up of Infertility Patients: A Pilot Study The goal of this study is to use the Nurse’ Health Study to assess the effects of fertility treatment on long-term health, including cardiovascular, endocrine, rheumatological and cancer diagnoses/ diseases.

9

Principal Academic, Clinical and Hospital Service Responsibilities:

1986-1990 Director, George and Olive Smith Endocrine Laboratory, Brigham and Women's Hospital, Boston, MA.

1986-1987 Associate Director, In Vitro Fertilization Program, Brigham and Women's Hospital, Boston, MA.

1986-1990 Chairman, User Committee, Radioimmunoassay Core, Laboratory of Human Reproduction and Reproductive Biology, Harvard Medical School, Boston, MA.

1989-1990 Director of Reproductive Endocrinology, Brigham and Women's Hospital, Boston, MA.

1990-1993 Chief of Obstetrics and Gynecology, University Hospital Health Sciences Center, State University of New York at Stony Brook, NY.

1990-1993 Program Director, Residency Training Program in Obstetrics and Gynecology, University Hospital, State University of New York at Stony Brook, NY.

1992-1993 Vice President, Clinical Practice Management Plan, Health Sciences Center, Stony Brook, NY.

1992-1993 Vice President, Medical Staff, University Hospital, Stony Brook, NY.

1993- Chief of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA.

1993-2004 Program Director, Residency Training Program in Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA.

1993- Care Improvement Council - Brigham and Women's Hospital. 1994-1996 Primary Care Task Force - Massachusetts General Hospital -

Brigham and Women's Hospital. 1996-2008 Harvard Medical School, Academic Societies Committee on Careers. 1998-1999 Chair, Internal Review Committee for Emergency

Medicine. 1999-2005 Board of Trustees, Brigham and Women’s Hospital 1999-2002 Specialty Care Development Committee, Partner’s HealthCare. 2000-2004 Chair, Executive Committee, Brigham and Women’s Hospital Physicians’ Organization. 2001-2002 Chair, Harvard Medical School Committee to Search for

Chief of Anesthesia, Brigham and Women’s Hospital. 2001-2004 Harvard Medical School, Minority Faculty Development Program Advisory Committee.

2004- Board of Directors, Center for Medical Simulation. 2008-2012 Chair, Executive Committee, Brigham and Women’s Hospital

Physician Organization

Barbieri C.V. 10

Principal Academic, Clinical and Hospital Service Responsibilities (continued):

2008-2012 Chair, Board of Trustees, Brigham and Women’s Hospital Physicians’ Organization.

2008-2012 Board of Trustees, Brigham and Women’s Hospital 2010- Program Advisory Committee. Harvard School of Public Health, Program for Chiefs of Clinical Services. 2010 Chair, Harvard Medical School Dean’s Advisory Council on

Departmental Status for Emergency Medicine. 2011-2013 Harvard Medical School Continuing Medical Education

Review Committee 2012-2013 Chair, Harvard Medical School ad hoc committee to search for

a Chair, BWH, Department of Pediatric Newborn Medicine. 2012-2015 Subcommittee of Professors, Harvard Medical School. 2014-2015 Harvard Medical School ad hoc committee to search for a

Chair, BWH Department of Anesthesia. 2014-2015 Harvard Medical School ad hoc committee to search for a

Chair, MGH Department of Obstetrics, Gynecology and Reproductive Biology.

2015-2016 Chair, Harvard Medical School ad hoc committee to search for a Chair, BWH, Department of Emergency Medicine.

11

Teaching Experience: 1978-1982 Postgraduate Course in Reproductive Endocrinology,

Brigham and Women's Hospital. Lecture: Steroid Biochemistry.

1982-1983 Postgraduate Course in Gynecology, Massachusetts General Hospital. Lecture: Endometriosis.

1982-1986 Reproductive Endocrinology Seminar Series, Massachusetts General Hospital. Lecture: Endometriosis.

1983-1985 Postgraduate Course in Obstetrics and Gynecology, Harvard Medical School. Lectures: (1) Galactorrhea- Amenorrhea Syndromes, (2) Ovarian Steroidogenesis, (3) LHRH Agonists and Antagonists.

1984-1987 Reproductive Pathophysiology Course, Harvard Medical School. (1) Section Leader, (2) Lecture: Menstrual Cycle.

1985 Endocrine Grand Rounds, Brigham and Women's Hospital: "The Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome".

1985 Obstetrics and Gynecology Grand Rounds, Brigham and Women's Hospital: "Endocrinology of the Menstrual Cycle".

1985 Obstetrics and Gynecology Grand Rounds, St. Margaret's Hospital, Tufts Medical School: "Endocrinology of the Menstrual Cycle".

1985 Obstetrics and Gynecology Grand Rounds, Royal Victoria Hospital, McGill University, Montreal "Hyperandrogenism and Insulin Resistance".

1985 Obstetrics and Gynecology Grand Rounds, St. Margaret's Hospital, Tufts Medical School: "Endocrinology of the Menstrual Cycle".

1985 Gynecology Grand Rounds, Massachusetts General Hospital: "Endometriosis".

1985 Obstetrics and Gynecology Grand Rounds, The Western Pennsylvania Hospital: "Hyperprolactinemia".

1985 Massachusetts Institute of Technology Mellon Program: Science for the Liberal Arts Professor: "Ovulation and Fertilization".

1985 Baker-Channing Society Quinquennial Scientific Conference: "The Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome".

1985 New York University Endometriosis Symposium: "The Endocrine Pharmacology of Danazol".

1985 Harvard Joint Program in Neonatology Grand Rounds: "Endocrinology of the High Risk Pregnancy".

1985 Obstetrics and Gynecology Grand Rounds, Salem Hospital: "Endometriosis".

Barbieri C.V. 12

Teaching Experience (continued): 1986 Obstetrics and Gynecology Grand Rounds, Brigham and

Women’s Hospital: “Effects on Constituents of Cigarette Smoke on Reproduction”.

1986 Postgraduate Course in Gynecology, Massachusetts General Hospital. Lecture: "Endometriosis".

1986 Postgraduate Course in Obstetrics and Gynecology, Harvard Medical School. Lectures: (1) Hirsutism, Polycystic Ovary Syndrome, (2) Advances in the Treatment of Benign Gynecologic Diseases: Fibroids, Endometriosis.

1986 Obstetrics and Gynecology Grand Rounds, Boston City Hospital. Lecture: "Advances in the Diagnosis and Management of Endometriosis".

1986 Obstetrics and Gynecology Grand Rounds, University of Connecticut Medical School, Farmington: "The Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome".

1986 Reproductive Endocrinology Conference, Yale University School of Medicine, New Haven, CT: "The Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome".

1986 American Gynecological Club Annual Meeting. Lecture: "The HAIR-AN Syndrome".

1986 Obstetrics and Gynecology Grand Rounds, St. Margaret's Hospital, Tufts Medical School: “Evaluation of the Hyperandrogenic Female".

1986-1987 Core Clerkship in Obstetrics and Gynecology, Harvard Medical School. Lecture: "Endometriosis and Leiomyomata Uteri".

1986-1988 Reproductive Pathophysiology, Harvard Science and Technology Program. Lecture: "Menstrual Cycle".

1987 Obstetrics and Gynecology Grand Rounds, Maine Medical Center: “Advances in the Diagnosis and Management of Endometriosis".

1987 Obstetrics and Gynecology Grand Rounds, University of Connecticut School of Medicine: "Hirsutism and Hyperandrogenism".

1987 Obstetrics and Gynecology Grand Rounds, University of Maryland: "The Endocrine Pharmacology of Danazol".

1987 Obstetrics and Gynecology Grand Rounds, Brigham and Women's Hospital: "Polycystic Ovary Syndrome".

1987 Reproductive Pathophysiology, New Pathway Program, Harvard Medical School: "Menstrual Cycle and Early Pregnancy Events".

13

Teaching Experience (continued):

1987 Postgraduate Course in Reproductive Endocrinology, Harvard Medical School. Lectures: (1) Ovarian Physiology, (2) Polycystic Ovary Syndrome, (3) Modern Laboratory Techniques, (4) Endocrinology in Pregnancy.

1987 Endocrine Society Meeting, Polycystic Ovary Syndrome Symposium, Indianapolis: "The Role of Hyperinsulinemia in the Pathogenesis of PCO".

1987 American College of Surgeons Meeting, Endometriosis Symposium, San Francisco: "The Use of CA-125 in the Diagnosis of Endometriosis".

1987 Postgraduate Course in Gynecology, Massachusetts General Hospital. Lecture: "Endometriosis".

1987 Postgraduate Course in Reproductive Endocrinology and Infertility, Boston University School of Medicine. Lectures: (1) Physiology of the Menstrual Cycle, (2) Ovulatory Failure or Anovulation.

1987 Endocrine Grand Rounds, Brigham and Women's Hospital, Boston, MA. Lecture: "Hyperinsulinemia and Hyperandrogenism".

1987 Postgraduate Medical Institute, Dedham, MA. Lecture: "Office Gynecology".

1988 Reproductive Endocrinology Series, University Connecticut School of Medicine, Farmington, CT. Lecture: "Steroidogenesis".

1988 Clinical Correlation Leader, Core Clerkship in Obstetrics and Gynecology, Harvard Medical School.

1988 Tutor, Genetics, Embryology and Reproduction Course, Harvard Medical School.

1988 Co-Chairman, American Association for the Advancement of Science Symposium, Boston, MA Lecture: Effects of Intensive Exercise on Female and Male Reproduction.

1988 Society for Gynecologic Investigation Symposium, Atlanta, GA. Lecture: "Effects of Components of Cigarette Smoke on Steroid Production and Metabolism".

1988 Reproductive Endocrinology Seminar Series, Massachusetts General Hospital. Lecture: "Hyperandrogenism, Insulin Resistance and Acanthosis Nigricans".

1988 Endocrinology Seminar Series, Joslin Clinic: "Diagnostic Evaluation and Therapy of Hyperandrogenism".

1988 Endocrinology Seminar Series, Brown University School of Medicine, Providence, RI. Lecture: "Hyperinsulinemia and Hyperandrogenism: Cause and Effect".

Barbieri C.V. 14

Teaching Experience (continued): 1988 Endocrinology Seminar Series, University of Minnesota School

of Medicine, Minneapolis, MN. Lecture: "Danazol: Endocrine Pharmacology and Therapeutic Applications".

1988 Endocrinology Seminar Series, University of Minnesota School of Medicine, Minneapolis, MN: Lecture: "Hyperinsulinemia and Hyperandrogenism: Cause and Effect".

1988 Obstetrics and Gynecology Grand Rounds, St. Margaret's Hospital, Boston, MA. Lecture: “Leuprolide Acetate Applications in Gynecology".

1988 Obstetrics and Gynecology Grand Rounds, Rutland Regional Hospital, Rutland, VT. Lecture: “Endometriosis 1988".

1988 Obstetrics and Gynecology Grand Rounds, Beth Israel Hospital, Boston, MA. Lecture: "GnRH Agonists: Applications in Gynecology".

1988 Intensive Review Course in Gynecology, Massachusetts General Hospital, Boston, MA: "Endometriosis".

1988 Intensive Review Course in Reproductive Endocrinology, Massachusetts General Hospital, Boston, MA. "Feto-Placental Endocrinology".

1988 American Fertility Society Roundtable: Atlanta, GA. "The Role of Hyperinsulinemia in the Pathogenesis of Ovarian Hyperandrogenism".

1988 American Fertility Society Post-Graduate Course Reproductive Endocrinology for the Practicing Gynecologist. Lectures: (1) Hyperandrogenism and Hirsutism, (2) GnRH Agonists, (3) Endocrinology of Pregnancy, (4) Pregnancy in the Infertile Patient (5) Medical Therapy for endometriosis and (6) Hyperprolactinemia, San Antonio, TX.

1988 Albert Einstein School of Medicine Postgraduate Course in Obstetrics and Gynecology. Lecture: "GnRH Agonists." New York, NY.

1988 Mount Auburn Hospital Postgraduate Course in Obstetrics and Gynecology. Lectures: (1) Medical Therapy of Endometriosis (2) Medical Therapy of Leiomyomata Uteri. Cambridge, MA.

1988 Massachusetts General Hospital, Reproductive Endocrine Clinical Conference Series. Lecture: "Acanthosis Nigricans and Insulin Resistance" Boston, MA.

1988 Department of Obstetrics and Gynecology Grand Rounds, University of Vermont Medical Center, Burlington, VT. Lecture: "Applications of GnRH-Agonists in Gynecology."

1989 Harvard Medical School, Reproductive Pathophysiology Block; Lecture: "The Menstrual Cycle" Boston, MA.

15

Teaching Experience (continued):

1989 Department of Obstetrics and Gynecology, Grand Rounds,

Newton-Wellesley Hospital. Lecture: "Applications of GnRH Agonists in Gynecology" Newton, MA.

1989 Harvard Medical School; Reproductive Pathophysiology Block, Section Leader, Boston, MA.

1989 Department of Medicine, Endocrinology Grand Rounds, Beth Israel Hospital. Lecture: "Hyperandrogenism and Insulin Resistance." Boston, MA.

1989 Harvard Medical School, New Pathway Block, Human Systems. Lecture: “The Menstrual Cycle." Boston, MA

1989 Harvard Medical School, Genetics, Embryology and Reproduction Block, Tutor.

1989 Harvard Medical School, Genetics, Embryology and Reproduction Block, Lecture: "Endocrinology of Pregnancy".

1989 Department of Obstetrics and Gynecology, Grand Rounds, Emerson Hospital, Lecture: Leuprolide acetate applications in gynecology. Concord, MA.

1989 Harvard Medical School, Postgraduate Course in Obstetrics and Gynecology. Lectures: (1) Mechanism of Hormone Action, (2) Polycystic Ovary Syndrome, (3) Workshop: Menstrual Disorders.

1989 University of Massachusetts Medical Center, Obstetrics and Gynecology Grand Rounds. Lecture: Applications of GnRH-Agonists in Gynecology Worcester, MA.

1989 Cincinnati Obstetrics and Gynecology Society. Lecture: Use of GnRH-Agonists in the treatment of leiomyomata uteri. Cincinnati, OH.

1989 Hartford Hospital, Obstetrics and Gynecology, Grand Rounds. Lecture: Applications of GnRH-Agonists in Gynecology. Hartford, CT.

1989 Harvard-MIT, Health Science and Technology Program, Reproductive Pathophysiology Block. Lecture: Menstrual Cycle.

1989 Second International Symposium on Endometriosis. Lecture: Danazol. Houston, TX.

1989 Second International Symposium on Endometriosis. Invited Speaker. Roundtable: Medical Therapy of Endometriosis. Houston, TX.

Barbieri C.V. 16

Teaching Experience (continued):

1989 International Symposium on Nafarelin. Chairman. Lectures: (1) Epidemiology and Etiology of Endometriosis, (2) Comparison of the Pharmacology of Nafarelin and Danazol and (3) Nafarelin and Estrogen-Progestogen Replacement Therapy.

1989 Joslin Clinic. Endocrinology Rounds. Lecture: Hyperandrogenism in Women," Boston, MA.

1989 Massachusetts General Hospital, Advances in Gynecology Postgraduate Course. Lecture: "Endometriosis" Boston, MA.

1989 Massachusetts General Hospital, Reproductive Endocrinology Postgraduate Course. Lecture: Advances in the Management of Endometriosis. Boston, MA.

1989 Brigham and Women's Hospital Medical Staff Alumni Association. Lecture: Hyperinsulinemia and Hyperandrogenism: Cause and Effect. Boston, MA.

1989 Core Curriculum - Modern Medicine. Lectures: Contraceptive Options, Pelvic Pain, Pelvic Infection. Dedham, MA.

1989 Jefferson Medical College - Obstetrics and Gynecology Grand Rounds. Lecture: Leiomyomata Uteri: Pathogenesis and Treatment. Philadelphia, PA.

1989 Harvard Community Health Plan-Obstetrics and Gynecology Rounds. Lecture: Medical Therapy of Endometriosis, Boston MA.

1989 Burbank Hospital. Obstetrics and Gynecology Rounds. Lecture: GnRH Agonists. Applications in Gynecology, Fitchburg, MA.

1990 Columbia Hospital for Women. Obstetrics and Gynecology Grand Rounds. Lecture: GnRH Agonists: Applications in Gynecology, Washington, D.C.

1990 SUNY Stony Brook. Postgraduate Course Family Practice. Lecture: Contraception, Stony Brook, NY.

1990 Albert Einstein Hospital. Obstetrics and Gynecology Grand Rounds. Lecture: GnRH Agonists: Applications in Gynecology, NY, NY.

1990 Queens Hospital Center. Obstetrics and Gynecology Grand Rounds. Lecture: Pathophysiology and Treatment of Leiomyomata Uteri, NY, NY.

1990 Suffolk County Obstetrical Society. Lecture: Polycystic Ovary Syndrome. Hauppauge, NY.

1990 ACOG District I Regional Postgraduate Course Lectures: (1) Hyperinsulinemia and Hyperandrogenism in Women and (2) Pathophysiology and Treatment of Leiomyomata Uteri. Portland, ME.

17

1990 American Fertility Society Regional Postgraduate Course. Lectures: (1) The Clinical Use of GnRH Agonists, (2) Endometriosis, (3) Non-central Ovulatory Problems, and (4) Polycystic Ovaries and Insulin. Vancouver, British Columbia, Canada.

1990 ACOG Massachusetts District Regional Postgraduate Course. Lecture: Medical Therapy of Endometriosis. Gloucester, MA.

1990 National Institute of Health. Polycystic Ovarian Disease Conference. Lecture: Effects of Insulin on the Ovary. Bethesda, MD.

1990 North Shore University Hospital, Department of Obstetrics and Gynecology, Grand Rounds. Lecture: Polycystic Ovary Syndrome. Great Neck, NY.

1990 Winthrop University Hospital. Obstetrics and Gynecology Grand Rounds. Lecture: Genetic Causes of the Polycystic Ovary Syndrome, Mineola, NY.

1990 Long Island Jewish Hospital. Obstetrics and Gynecology Grand Rounds. Lecture: GnRH Analogs in the Treatment of Leiomyomata Uteri, New Hyde Park, NY.

1990 American Fertility Society. Twenty Third Annual Postgraduate Course. Chairman. Medical Endocrinology for Clinical Practice. Lectures: (1) Polycystic Ovaries and Hyperinsulinemia (2) Feto-Placental Endocrinology. Washington, D.C.

1990 Nassau County Medical Center. Obstetrics and Gynecology Grand Rounds. Lecture: Pathophysiology of Leiomyomata Uteri, East Meadow, NY.

1990 SUNY Stony Brook Obstetrics and Gynecology Grand Rounds. Lecture: Pathophysiology and Treatment of Leiomyomata Uteri. Stony Brook, NY.

1990 Clini Chem 90. American Association for Clinical Chemistry. Lecture: Advanced Clinical Applications of Gynecologic Endocrine Analysis. Hartford, CT.

1990 Massachusetts General Hospital. Gynecology Grand Rounds. Lecture: Medical Therapy of Endometriosis. Boston, MA.

1990 University of Maryland, Department of Obstetrics and Gynecology Grand Rounds. Lecture: Somatic Mutations in Leiomyoma Uteri, Baltimore, MD.

1990 Franklin Square Hospital, Department of Obstetrics and Gynecology Grand Rounds. Lecture: Medical Management of Endometriosis. Baltimore, MD.

1991 Johns Hopkins University, Department of Obstetrics and Gynecology Grand Rounds. Lecture: Genetic Causes of the Polycystic Ovary Syndrome. Baltimore, MD.

Barbieri C.V. 18

Teaching Experience (continued): 1991 American College of Obstetricians and Gynecologists, Rhode

Island Section. Lecture: Medical Management of Endometriosis. Providence, RI.

1991 Physiology and Biochemistry Course. Clinical Correlation Lecture: In Vitro Fertilization. S.U.N.Y. Stony Brook, NY.

1991 Medicine in Contemporary Society II. Lecture: Regulating Reproduction: In Vitro Fertilization, S.U.N.Y. Stony Brook, NY.

1991 Suffolk County Obstetrics and Gynecology Society, Clinic Day. Lecture: Medical Management of Endometriosis.

1991 New York Obstetrical Society Lecture: The Effects of Cigarette Smoking on Steroidogenesis. New York, NY.

1991 Brigham and Women's Hospital. Department of Obstetrics and Gynecology Postgraduate Course. Lecture: Polycystic Ovary Syndrome. Boston, MA.

1991 Brookdale Hospital Center, Obstetrics and Gynecology Grand Rounds. Lecture. GnRH Analogs: Current Applications. Brooklyn, NY.

1991 North Central Bronx-Lebanon Hospital, Department of Obstetrics and Gynecology Grand Rounds, Lecture: Endometriosis. Bronx, NY

1991 Laboratory of Human Reproduction and Reproductive Biology. Harvard Medical School. Lecture: Genetic Causes of Hyperandrogenism.

1991 American Fertility Society Regional Postgraduate Course. Lectures: (1) Hyperinsulinemia and Hyperandrogenism, (2) Physiology of the Menopause. Washington, DC.

1991 American College of Obstetricians and Gynecologists Annual Clinical Meeting; 060 Postgraduate Course: Clinical Endocrinology. Lectures: (1) Hyperpro-lactinemia, (2) Treatment of the Menopause, (3) Polycystic Ovary Syndrome. New Orleans, LA.

1991 Radius Scientific Symposium: GnRH Analogs: Optimal Management Strategies. Chairman and Lecture: The Estrogen Threshold Hypothesis. New Orleans, LA.

1991 Reproductive Physiology Systems Course, Health Sciences Center, S.U.N.Y. Stony Brook. Lecture: Infertility.

1991 Queens Obstetrical Society. Lecture: GnRH Analogs Future Therapies. North Hills, NY.

1991 New York Medical College, Obstetrics and Gynecology Grand Rounds. Lecture: Advances in the Treatment of Endometriosis. Valhalla, NY.

1991 Organ Systems. Female Reproductive System. Lectures: (1) Control of the menstrual cycle, (2) Physiology of the Mullerian system, (3) Endocrinology of pregnancy. S.U.N.Y. Stony Brook, NY.

19

Teaching Experience (continued): 1991 G. Robert Rigsby Lecture Series. New England Memorial

Hospital. Lecture: Endometriosis Update. Boston, MA. 1991 Long Island College Hospital. Obstetrical and Gynecology

Grand Rounds. Lecture: Contraception. Brooklyn, NY. 1991 Saint Raphael's Hospital. Obstetrics and Gynecology Grand

Rounds. Lecture: GnRH agonists: Current and future therapies. New Haven, CT.

1991 University of Medicine and Dentistry of New Jersey. Department of Obstetrics and Gynecology Grand Rounds. Lecture: Pathophysiology and treatment of myomas. Newark, NJ.

1991 University of Pennsylvania. Department of Obstetrics and Gynecology. John Rock Memorial Lecture: Pathophysiology and treatment of myomas. Philadelphia, PA.

1991 University of Connecticut. Department of Obstetrics and Gynecology Grand Rounds. Lecture: Pathophysiology and treatment of myomas. Farmington, CT.

1991 State University of New York, Downstate Department of Obstetrics and Gynecology Grand Rounds. Lecture: Pathophysiology of leiomyomas. Brooklyn, NY.

1991 Cornell University School of Medicine, Department of Obstetrics and Gynecology Grand Rounds. Lecture: Biology and Treatment of Uterine Myomas. New York, NY.

1991 American Fertility Society. Postgraduate Course: Medical and Reproductive Endocrinology for the Clinician. Chairman. Lecture: The Estrogen Threshold Hypothesis. Orlando, FL.

1991 American Fertility Society. Workshop: Preventable Infertility. Orlando, FL.

1991 American Fertility Society. Roundtable: The Medical Treatment of Endometriosis. Orlando, FL.

1991 Massachusetts General Hospital Reproductive Endocrinology Post Graduate Course. Lectures: Endocrinology of Pregnancy, Hirsutism. Boston, MA.

1991 McGill University Department of Obstetrics and Gynecology Grand Rounds. "Uterine Leiomyomas: Pathophysiology and Treatment." Montreal, Canada.

1991 University of Montreal, St. Luc Hospital, Department of Obstetrics and Gynecology. "Endometriosis: Surgical and Hormonal Treatment."

1991 Albert Einstein School of Medicine, Department of Obstetrics and Gynecology Postgraduate Course. Lectures: (1) Smoking, Diet, Exercise and Ovarian Function, (2) GnRH analogues and estrogen-progestogen add-back. New York, NY.

Barbieri C.V. 20

Teaching Experience (continued): 1991 Brooklyn Obstetrical Society. Lecture: Leiomyomata Uteri:

Pathophysiology and Treatment. Brooklyn, NY. 1991 Jersey Shore Medical Center, Department of Obstetrics and

Gynecology Grand Rounds. Lecture: Leiomyomata Uteri: Pathophysiology and Treatment. Neptune, NJ.

1991 Fairfield County Obstetrical and Gynecological Society. Title: Endometriosis. Darien, CT.

1991 State University of New York at Stony Brook, Molecules, Genes and Cells Course. Lecture: In Vitro Fertilization.

1992 Obstetrical Society of Philadelphia. Lecture: Genetic causes of the polycystic ovary syndrome. Philadelphia, PA.

1992 Temple University School of Medicine, Department of Obstetrics and Gynecology Grand Rounds. Lectures: Pathophysiology of Uterine Myomas; Environmental Effects on Reproduction. Philadelphia, PA.

1992 Columbia University School of Medicine, Department of Obstetrics and Gynecology Grand Rounds. Lecture: Pathophysiology and Treatment of Uterine Myomas. New York, NY.

1992 Harvard Medical School, Obstetrics and Gynecology Postgraduate Course. Lecture: Secondary-Amenorrhea. Boston, MA.

1992 SUNY Stony Brook, Family Medicine Postgraduate Course. Lecture: Menstrual Disorders.

1992 Winthrop University Hospital, Department of Medicine, Endocrine Conference. Lecture: The Polycystic Ovary Syndrome. Mineola, NY.

1992 Good Samaritan Hospital Grand Rounds, Department of Obstetrics and Gynecology. Lecture: Office Reproductive Endocrinology. West Islip, NY.

1992 American Fertility Society - Annual Meeting - Round Table - Medical Treatment of Endometriosis, New Orleans, LA.

1992 American Fertility Society - Postgraduate Course. Chairman. Course Title: Medical and Reproductive Endocrinology for Clinical Practice. Lectures: 1) Endocrine evaluation of pituitary function, 2) Hypothyroidism and hyperthyroidism and 3) Endocrinology of Pregnancy. Case Presentations: 1) Management of adrenal hyperplasia in the infertile female, 2) Treatment of hypercalcemia with steroid hormones, 3) Endocrine management after pituitary surgery, 4) Hyper-androgenism, insulin resistance and acanthosis nigricans syndrome, New Orleans, LA.

1992 American Fertility Society - Annual Meeting. Seminar: From Precocity to PMS: All Today's uses for GnRH Analogs. New Orleans, LA.

21

Teaching Experience (continued): 1992 University of California, San Francisco – Annual Post

Graduate Course. Lectures: 1) Hyperandrogenism, Insulin Resistance and Acanthosis Nigricans Syndrome, 2) Effects of Cigarette Smoke, Milk and Alcohol on Reproduction, and 3) Myomata Uteri: Etiology and Management. San Francisco, CA.

1993 Brigham and Women's Hospital, Harvard Medical School, Department of Obstetrics and Gynecology Postgraduate Course. Lectures: 1) Hyperandrogenism: Pathophysiology and Treatment, 2) Amenorrhea: Pathophysiology, Management and Treatment.

1993 University of California San Francisco, Department of Obstetrics and Gynecology Grand Rounds. Lecture: Uterine Myomas: Pathophysiology and Treatment. San Francisco, CA.

1993 San Francisco Obstetrics and Gynecology Society. Lecture: Estrogen Threshold Hypothesis. San Francisco, CA.

1993 American Heart Association Symposium. Women and Heart Disease. Lecture: Estrogen Replacement Therapy. Uniondale, NY.

1993 Maurice Goldenhar Nineteenth Annual Family Medicine Update. SUNY Stony Brook Lecture: Family Planning.

1993 Hartford Hospital. Obstetrics and Gynecology Grand Rounds Lecture: Uterine Leiomyomata: Pathobiology and Treatment. Hartford, CT.

1993 American Fertility Society. Regional Postgraduate Course. Lectures: 1) Hyperandrogenism Syndromes, 2) Endometriosis: Medical and Surgical Therapy, 3) Uterine Leiomyomas: Pathophysiology and Management, 4) Hormone Replacement Therapy. Mackinac Island, MI.

1993 American Fertility Society. Twenty-sixth Annual Postgraduate Course. Chairman: Medical and Reproductive Endocrinology for Clinical Practice. Lectures: 1) Endocrinology of Pregnancy, 2) The New Progestins and 3) Clinical Pharmacology of GnRH. Montreal, Canada.

1993 American Fertility Society. Mini Symposium: "Hyperandrogenism and Insulin Resistance. Montreal Canada.

1993 Brigham and Women's Hospital, Department of Medicine Grand Rounds. Lecture: Application of GnRH Agonists in Gynecology, Boston, MA.

1994 Brigham and Women's Hospital, Harvard Medical School, Department of Obstetrics and Gynecology Postgraduate Course Lectures. 1) Hyperandrogenism - evaluation and treatment, 2) Endometriosis Workshop.

1994 Harvard Medical School Human Systems Course. Lecture: Changes in the Hypothalamic Pituitary Ovarian Axis.

Barbieri C.V. 22

Teaching Experience (continued): 1994 National Institutes of Health Symposium: Alternatives to

Hysterectomy. Lecture: Future Directions. Bethesda, MD. 1994 Harvard Community Health Plan, Women's Health

Conference, Lecture: Hormone Treatment in the Management of the Perimenopause.

1994 Washington University School of Medicine. Frontiers in Ovulation Induction. Lecture: Pituitary-Ovarian Interactions During Ovulation.

1994 University of Rochester School of Medicine. Fourteenth Annual Jerome H. Rudolph, M.D. Memorial Lecture: Genetic Causes of Ovarian Hyperandrogenism.

1994 University of Rochester School of Medicine. Visiting Professor Lecture: "Leiomyomata Uteri: Genetic Causes and Estrogen Hyper-responsivity".

1994 Massachusetts General Hospital Reproductive Endocrinology Postgraduate Course. Lecture: "An Overview of Assisted Reproductive Technologies."

1995 Langley Seminar Series, Oregon Health Sciences University. Lecture: "Hyperinsulinemia and Hyperandrogenism", "Premature Loss of Ovarian Follicles". Portland, OR.

1995 Boston Obstetrical Society. Discussant: The Obstetrician-Gynecologist and Primary Care.

1995 Baylor College of Medicine, Department of Obstetrics and Gynecology Grand Rounds. Lecture: Endometriosis: Update 1995. Houston, TX.

1995 University of Texas, Department of Obstetrics and Gynecology Grand Rounds. Lecture: Uterine Leiomyomata: The somatic mutation hypothesis. Houston, TX.

1995 Serono Symposium: Polycystic Ovary Syndrome. Lecture: Genetic Regulation of Steroid Synthesis: Implications for PCO. Boston, MA.

1995 Women in Academic Medicine. Lecture: Developing Managerial Expertise: Becoming a Better Manager. Harvard Medical School. Boston, MA.

1995 Boston University Medical Center, Obstetrics and Gynecology Grand Rounds. Lecture: Uterine Myomas and Endometriosis. Boston, MA

1995 Endometriosis Association, Presentation: Cervical Disease and Endometriosis. Boston, MA

1995 Resolve. Taking Charge of Your Infertility. Presentation: Ovulation Disorders.

1995 Children’s Hospital Postgraduate Course. Pediatric and Adolescent Gynecology. Lecture: Polycystic Ovary Syndrome.

23

Teaching Experience (continued): 1995 Massachusetts General Hospital Postgraduate Course.

Reproductive Endocrinology for Practicing Physicians. Lecture: An Overview of Assisted Reproductive Technology.

1996 Fosamax Regional Meeting. Lecture: Estrogen to Fosamax: Creating a New Treatment Algorithm. Boston, MA

1996 Medical Education Collaborative. Faculty Update. Lecture: Gynecology Practice in the 90’s. Renaissance or Dark Ages. Calgary, Canada.

1996 Buffalo Obstetrics and Gynecology Society. Lecture: Uterine Myomas a Disease in Search of a Gene. Buffalo, NY.

1996 University of Buffalo, Department of Obstetrics and Gynecology, Grand Rounds. Lecture: Estrogen Action and Metabolism: The Estradiol Target. Buffalo, NY.

1996 Michael Reese Hospital, Department of Obstetrics and Gynecology. Grand Rounds. Lecture: Estrogen Responsiveness in Women. Chicago, IL.

1996 Illinois Masonic Medical Center, Department of Obstetrics and Gynecology, Grand Rounds. Lecture: Endometriosis 1996: An Update. Chicago, IL.

1996 University of Illinois, Department of Obstetrics and Gynecology, Grand Rounds. Lecture: Hyperandrogenism; Diagnosis and Treatment. Chicago, IL.

1996 Rush-Presbyterian-St. Luke’s Medical Center, Department of Obstetrics and Gynecology, Grand Rounds. Lecture: Uterine Myomas: A Disease in Search of a Gene. Chicago, IL.

1996 Massachusetts General Hospital Reproductive Endocrine Clinic Conference Series. Lecture: The Endocrinology of Pregnancy.

1996 Harvard Medical School Reproductive Pathophysiology. Lecture: Menstrual Cycle Dysfunction

1996 Massachusetts Medical Society. Presentation: Information to help land the right residency. Boston, MA.

1996 Johns Hopkins School of Medicine. Department of Obstetrics and Gynecology Grand Rounds. Lecture: Genetic Causes of Uterine Leiomyomata. Baltimore, MD.

1996 Union Memorial Hospital. Department of Obstetrics and Gynecology Grand Rounds. Lecture: Genetic Causes of Uterine Leiomyomata. Baltimore, MD.

1996 Children’s Hospital Postgraduate Course. Pediatric and Adolescent Gynecology. Lecture: Polycystic Ovarian Disease. Boston, MA.

1996 Beth Israel Hospital Endocrine Grand Rounds. Lecture: Endocrine Treatment of Endometriosis and Uterine Leiomyomata. Boston MA

Barbieri C.V. 24

Teaching Experience (continued): 1996 American Society of Reproductive Medicine Annual Meeting.

Associate Members Meeting. Lecture: Challenges of an Academic Chairman in the 1990’s. Boston, MA

1996 Mount Sinai School of Medicine. Pediatric and Adolescent Gynecology Postgraduate Course. Lecture: Polycystic Ovarian Disease. New York, NY

1997 Ob-Gyn Update and Maternal-Fetal Medicine Update. University of Utah. Lectures: Endometriosis: Update 1997; Polycystic Ovary Disease: Hirsutism and Acne; Osteoporosis. Park City, UT.

1997 Brigham and Women’s Hospital. Department of Obstetrics and Gynecology, Postgraduate Course. Lecture: Hyperandrogenism-Polycystic Ovary Syndrome. Boston, MA

1997 Medical Education Collaborative. New Directions in the Management of the Female Patient. Lecture: Use of GnRH for laparscopically confirmed endometriosis. Cancun, Mexico

1997 Winthrop University Hospital. Department of Obstetrics and Gynecology Grand Rounds. Lecture: Endometriosis: Update 1997. Boston, MA

1997 University of Massachusetts Medical School. Department of Obstetrics and Gynecology Grand Rounds. Lecture: Obesity and its Consequences on Reproductive Function and Pregnancy. Worcester, MA

1997 Harvard Medical School. Human Systems Course. Lecture: Menstrual Cycle and Abnormalities. Boston, MA

1997 Boston University School of Medicine. Internal Medicine Grand Rounds. Lecture: Polycystic Ovary Syndrome. Boston, MA

1997, 1998 Massachusetts General Hospital. Reproductive Endocrinology Rounds. Lecture: Unexplained Infertility. Boston, MA

1997 Maine Medical Center. Department of Obstetrics and Gynecology Grand Rounds. Lecture: Osteoporosis. Portland, ME

1997 American Society of Reproductive Medicine. Regional Post Graduate Course. Course Director. Lectures: 1) Osteoporosis, 2) Depressive Disorders in Women, 3) Obesity in Women and 4) Uterine Leiomyomata: New Treatments. San Francisco, CA.

1997 Medical Education Collaborative. “Current Issues and New Techniques in Gynecology”. Course Co-Director. Lectures: 1) Medical Management of Fibroids, 2) Endometriosis: An Overview and 3) The Empiric Treatment of Chronic Pelvic Pain. San Francisco, CA.

25

Teaching Experience (continued): 1997 Medical Education Collaborative. “Management of the Patient

with Endometriosis or Uterine Fibroids”. Course Co-Director. Lectures: 1) Chronic Pelvic Pain and 2) Long Term Use of GnRH Agonist: Add-back Therapy. Chicago, IL.

1997 Children’s Hospital Postgraduate Course. Pediatric and Adolescent Gynecology. Lecture: Polycystic Ovary Syndrome. Boston, MA.

1997 Summit on Women’s Health at Mid-Life. Study of Women’s Health Across the Nation. Seminar: Gynecologic Problems at Mid-Life (with Dr. Isaac Schiff). Boston, MA.

1997 New Haven Obstetrical and Gynecological Society. Lectures: Chronic Pelvic Pain, Wine and Women’s Health. New Haven, CT.

1997 American Society of Reproductive Medicine. Workshop: Current Management of Weight Control and Reproductive Problems (with Sarah Berga, MD) 53rd Annual Meeting. Cincinnati, OH.

1998 St. Elizabeth Medical Center, Department of Obstetrics and Gynecology Grand Rounds, Lecture: New Developments in the Treatment of Osteoporosis. Boston, MA.

1998 New Directions in the Management of the Female Patient. Course Director. Lecture: Use of GnRH Analogues Prior to Infertility Treatment and IVF. Fatardo, Puerto Rico.

1998 Harvard Medical School Pharmacology Course. Lecture: Contraceptive Pharmacology. Boston, MA.

1998 Core Curriculum In Primary Care Medicine. Lecture: Perimenopause, Menopause and Ovarian Failure. Dedham, MA.

1998 Brigham and Women’s Hospital Postgraduate Course. Lecture: Hyperandrogenism-Polycystic Ovary Syndrome. Boston, MA.

1998 New Britain General Hospital. Department of Obstetrics and Gynecology. Bristoll Lecture: Genetic Regulation and future Treatment of Fibroids. New Britain, CT.

1998 Winthrop University Hospital. Department of Obstetrics and Gynecology. Resident Research Day. Lecture: Wine and Women’s Health. Mineola, NY.

1998 Medical Education Collaborative Management of Gynecologic Disorders for the Next Millenium. Lecture: 1) Endometriosis and Pelvic Pain: Long Term Treatment Regimens. 2) Advances in the Pathophysiolophy of Endometriosis, Fibroids, and PCOS. Saratoga, NY.

Barbieri C.V. 26

Teaching Experience (continued):

1998 Endocrine Society Annual Meeting. Lecture: Meet the Professor - The Polycystic Ovary Syndrome. New Orleans, LA.

1998 Gynecology for the Next Millenium. Lectures: Management of Chronic Pelvic Pain, Adjunctive Medical Therapy for Endometriosis. Chicago, IL.

1998 Brigham and Women’s Hospital. Intensive Review of Internal Medicine. Lecture: Reproductive Endocrinology. Cambridge, MA.

1998 Children’s Hospital, Division of Gynecology and Adolescent Medicine. Pediatric and Adolescent Gynecology. Lecture: Pathogenesis and Approaches to PCOS in Adolescent Girls. Boston, MA.

1998 Newton-Wellesley Hospital. Menopause Management for the Next Millenium. Drs. R. Barbieri, T. Beatty, M.Rein, B. Walsh, L. Goodman, K. Isaacson. Partners Departments of Obstetrics and Gynecology

1998 New York Obstetrical Society. Lecture: Polycystic Ovary Syndrome: Metabolic, Cardiovascular and Reproductive Consequences.

1999 New England Medical Center. Department of Obstetrics and and Gynecology Grand Rounds Lecture: Endometriosis Update 1999 Boston, MA.

1999 Harvard Medical School; Pharmacology Course. Lecture: Contraceptive Pharmacology. Boston, MA.

1999 Leominster Hospital, Medical Grand Rounds. Lecture: Polycystic Ovary Syndrome: A Common Problem In Internal Medicine. Leominster, MA.

1999 Advanced Strategies to Maximize Success in Infertility. Course Co-Directors: Robert Barbieri, Gianpiero Palermo. Lecture: The Role of LH in Ovulation Induction: Is there a need? Naples Florida

1999 Mount Auburn Hospital. New Frontiers in Endocrinology. Lecture: Polycystic Ovarian Disease- New Perspectives. Newton Mass.

1999 Harvard Macy Institute Program for Leaders in Medical Education. Presentation: Clinical Faculty Development Boston Mass.

1999 Faulkner Hospital Medical Grand Rounds. Lecture: Reproductive Endocrinology for the Primary Care Clinician. Boston Mass.

27

Teaching Experience (continued): 1999 American Society of Reproductive Medicine. Thirty-Second

Annual Postgraduate Program. Chairperson for Course 1: Advanced Medical Endocrinology for Clinical Practice. Lecture: 1) Thyroid Diseases, 2) Endocrinology of Pregnancy, 3) Polycystic Ovary Syndrome, Toronto Canada.

1999 Children’s Hospital Pediatric and Adolescent Gynecology Postgraduate Course. Lecture: New Approaches to Hyperandrogynism, Hirsutism and PCOS in adolescent girls, Boston, Mass.

2000 Mount Auburn Hospital. Obstetrics and Gynecology Grand Rounds. Lecture: Polycystic Ovary Syndrome: New Perspectives. Boston, Mass.

2000 Harvard Medical School; Pharmacology Course. Lecture: Contraceptive Pharmacology, Boston, Mass.

2000 Emerson Hospital. Medical Staff Rounds. Polycystic Ovary Syndrome. Boston, MA

2000 Boston Medical Center; Department of Obstetrics and Gynecology Grand Rounds. Polycystic Ovary Syndrome. Boston, MA

2000 Brown University. Women and Infant’s Hospital, Resident Research Day. Lecture: Polycystic Ovary Syndrome: Reproductive and Metabolic Abnormalities. Providence, Rhode Island.

2000 S.U.N.Y. Stony Brook, Department of Obstetrics and Gynecology Grand Rounds. Lecture: Polycystic Ovary Syndrome.

2000 Brigham and Women’s Hospital, Women’s Health Forum. Lecture: Wine and Women’s Health

2000 Association of Managers of Gynecology and Obstetrics. Lecture: Physician Incentive-Compensation Plans.

2001-2004 Harvard Medical School; Pharmacology Course. Lecture: Contraceptive Pharmacology, Boston, MA. 2001 The X and Y: Current Trends in Gender-Specific Medicine

Harvard Medical School Postgraduate Course. Lecture: Contraception: Current Trends and Impact on Non-Reproductive Health. Boston, MA.

2001 National Institute of Child Health and Human Development. Symposium: Endometriosis: Emerging Research and Intervention Strategies. Presentation: The Relationship Between Endometriosis and Infertility. Bethesda, Maryland.

2001 Children’s Hospital Pediatrics Grand Rounds. Lecture: PCOS. Boston, MA.

2001-2004 Massachusetts General Hospital. Reproductive Endocrine Unit. Lecture: “Empirical Approaches to Unexplained Infertility.” Boston, MA.

Barbieri C.V. 28

Teaching Experience (continued): 2001 16th Isadore A. Siegel Memorial Lecture. University of

Maryland. Lecture: “Polycystic ovarian syndrome: advances in diagnosis and treatment. Baltimore, MD.

2001 Harvard-Macy Institute. Program for Leaders in Medical Education. Roundtable: Institutional Professional Development Programs. Boston, MA.

2001 Health Care, East and West, Moving Into the 21st Century. Break-out Group Leader. Harvard Medical International. Boston, MA.

2001 Harvard Medical School, Core Clerkship in Ob-Gyn; Lecture: Infertility, 8 times a year. Boston, MA.

2002 Association of Professors of Gynecology and Obstetrics Presidential Address: Great Mentors of the Past, Present and Tomorrow. Dallas, TX.

2002 The X and Y: Current trends in gender specific medicine. Harvard Medical School Postgraduate Course. Lecture: Polycystic Ovary Syndrome.

2002 The William E. Studdiford Jr. Visiting Professor, New York University. Lecture: The Polycystic Ovary Syndrome: From Birth to Menopause.

2002-2004 Harvard Macy Institute—Program for Leaders in Medical Education. Presentation: Sustaining the Academic Mission in the Clinical Environment. 2002 24th Annual Rose and Wilfred P. Cohen Lectureship in Obstetrics and Gynecology. North Shore University Hospital, Manhasset, NY. 2002 Melrose Wakefield Hospital. Medical Staff Grand Rounds. Topic: The Polycystic Ovary Syndrome. Melrose, MA. 2002 Brigham and Women’s Hospital Obstetrics and Gynecology Grand Rounds. Topic: Metformin in Gynecological Practice. Boston, MA. 2002 Mount Auburn Hospital, Obstetrics and Gynecology Grand

Rounds. Topic: Use of Metformin in Gynecological Practice. Cambridge, MA. 2003 Harvard Medical School, Core Clerkship in Obstetrics and

Gynecology. Topic: Infertility. 6 times per year. 2003 Newton Wellesley Hospital, Obstetrics and Gynecology Grand

Rounds. Topic: How to Use Metformin in Gynecology Practice. Newton, MA.

2003 Obstetrical and Gynecological Society of Suffolk County. Lectures: 1) The use of metformin in gynecology practice.

2) Endometriosis and pelvic pain: the use of long term “add-back” treatment.

29

Teaching Experience (continued):

2003 Massachusetts Medical Society Postgraduate Course, “Issues in the Treatment of Women.” Lecture: The Use of Metformin in Gynecology Practice. Burlington, MA.

2003 Harvard Medical School Postgraduate Course. Pediatric and Adolescent Gynecology. Lecture: “Androgen Disorders in Adolescents.” Boston, MA. 2003 Newton-Wellesley Hospital Pediatric Grand Rounds. Lecture: Androgen Disorders in Adolescents. Newton, MA. 2003 Winthrop University Hospital. Update in Obstetrics and Gynecology 2003. Lectures: 1) Uterine Fibroids: Etiology and Management. 2) Treatment of Hirsutism. Garden City, NJ. 2004 New York Society of Reproductive Medicine. Lecture: Polycystic Ovary Syndrome. New York, NY. 2004 University of Massachusetts, Department of Obstetrics and

Gynecology Grand Rounds. Lecture: The Use of Metformin in Gynecology Practice. Worcester, MA.

2004 Brigham and Women’s Hospital, Department of Obstetrics and Gynecology Grand Rounds. Lecture: Increasing the efficacy of clomiphene in general ob-gyn practice. Boston, MA.

2004 Brigham and Women’s Hospital. Center for Reproductive Medicine Rounds. Lecture: Aromatase inhibitors in reproductive medicine. Boston, MA.

2004 MetroWest Medical Center. Ob-Gyn Grand Rounds. Lecture: PCOS as a systemic disorder. Framingham, MA.

2004 Sidney Guzick Lecture, University of Rochester School of Medicine. Lecture: The clinical research database: lessons from endometriosis and uterine myomas. Rochester, NY.

2004 Massachusetts Medical Society—Massachusetts Section ACOG Annual Meeting. Lecture: Getting your patient pregnant with clomiphene. Burlington, MA.

2004 Brigham and Women’s Hospital. Primary Care Residency Seminar Series. Seminars: Hirsutism, Polycystic ovary syndrome.

2004 Harvard Medical School Continuing Medical Education Program: Clinical Advances in Obstetrics and Gynecology. Lectures: 1) The use of metformin in gynecological practice, 2) Treatment of osteoporosis, 3) Getting your patients pregnant with clomiphene.

2004-2011 Harvard Medical School Continuing Medical Education Program: Pediatric and Adolescent Gynecology. Lecture: Androgen disorders in adolescents.

2004 Winthrop Hospital Obstetrics and Gynecology Grand Rounds. Lecture: The use of metformin in gynecology practice. Mineola, NY.

Barbieri C.V. 30

Teaching Experience (continued): 2005 Harvard Medical School Continuing Medical Education

Program: Office Practice of Primary Care Medicine. Lecture: Polycystic ovary syndrome.

2005 St. Elizabeth’s Hospital. Department of Obstetrics and Gynecology. Lecture: Osteoporosis in young women. Brighton, MA.

2005 Suffolk County Obstetrics and Gynecology Society. Lectures: 1) Polycystic ovary syndrome: Boon or bane for your gynecology practice. 2) Fibroids of the anemic and famous. Islandic, NY.

2005 American College of Obstetricians and Gynecologists.

2005 District I Annual Meeting. Lecture: Current management of PCOS. Quebec City, Canada

2006-2009 Harvard Science and Technology, HMS Lecture: PCOS. Boston, MA. 2005, 2006, 2007 Harvard Medical School. Women’s and Children’s Midweek

Session. Presentation: Careers in Ob-Gyn. Boston, MA. 2005 Beth Israel Deaconess Endocrine Grand Rounds. Presentation:

PCOS. Boston, MA. 2005 Long Island Jewish Medical Center. Obstetrics and

Gynecology Grand Rounds. Presentations: 1) Fibroids of the anemic and famous. 2) PCOS. Long Island, NY

2006 Jewish General Hospital and St Mary’s Hospital. Practical Gynecology and Obstetrics. Lectures: 1) Medical management of pelvic pain. 2) Non-infertility management of women with PCOS. Montreal, Canada.

2006 Harvard University Health Service. Medical Grand Rounds. Lecture: PCOS and hirsutism: From adolescence to menopause. Cambridge, MA.

2006 Boston University School of Medicine. Obstetrics and Gynecology Grand Rounds. Lecture: Polycystic ovary syndrome.

2006 North Shore Medical Center. Obstetrics and Gynecology Grand Rounds. Lecture: Polycystic ovary syndrome.

2006 Harvard Medical School. The 27th Annual Office Practice of Primary Care Medicine. Lecture: Polycystic ovary syndrome. Boston, MA.

2006-2010 Harvard Medical School, Human Systems Lecture: Infertility and ART. Boston, MA.

2007 Harvard Medical School. The 28th Annual Office Practice of Primary Care Medicine. Lecture: Polycystic ovary syndrome. Boston, MA.

31

Teaching Experience (continued): 2007 South Shore Hospital. OB-GYN Grand Rounds. Lecture:

Polycystic ovary syndrome. S. Weymouth, MA. 2007, 2008 BWH Department of Medicine. Primary Care Resident Didactic Series. Lecture: PCOS. 2007, 09, 11, 12 Harvard Medical School, The 29th Annual Office Practice of Primary Care Medicine. Lecture: Abnormal vaginal bleeding. 2008, 2009 Suffolk Country OB-GYN Society. Lectures: 1) Fibroids of the

anemic and famous 2) Polycystic ovary syndrome. Islandia, NY.

2008 American College of Obstetricians and Gynecologists, Connecticut Section Annual Meeting. Lecture: Endometriosis and office infertility. New Britain, CT.

2008 79th Annual Meeting, New England Obstetrician and Gynecological Society. Lecture: Office Infertility: Clinical guidelines and pearls for the generalist. Sturbridge, MA.

2008 Beth Israel Deaconess Endocrine Fellows Rounds. Lecture: Polycystic ovary syndrome. Boston, MA.

2008 District I ACOG Annual Meeting. Lecture: Update in ob-gyn. Brewster, MA.

2008 Harvard Medical School. BCMP 235. Principles of Human Disease Physiology and Pharmacology. Lecture: Contraceptive pharmacology.

2008 Harvard Medical School. PRI-MED EAST. Lecture: Polycystic ovary syndrome. Boston, MA.

2008 Women’s Health Connecticut. Lecture: The future of practice, the practice of the future. Waterbury, CT.

2008-2010, 2014 Harvard School of Public Health. Course: Reproductive Epidemiology. Lecture: Polycystic ovary syndrome.

2009 Harvard Medical School. Clinical Advances in Obstetrics and Gynecology. Lectures: 1) Hyperandrogenism and the polycystic ovary syndrome, 2) Osteoporosis, 3) The difficult infertility patient.

2010 Newton-Wellesley Hospital. 1st John Yeransian Annual Lecture: Racing forward and looking back: 150 years of advances in gynecology.

2010 Brigham and Women’s Hospital Ob/Gyn Resident Didactic. Lecture: Osteoporosis.

2010 Harvard Medical School. The 31st Annual Office Practice of Primary Medicine. Lecture: Polycystic ovary syndrome.

2010- 2015 Harvard Medical School. Clinical Advances in Obstetrics and Gynecology. Lectures: 1) Hyperandrogenism and the polycystic ovary syndrome. 2) Osteoporosis

2010 Brigham and Women’s Hospital. Demystifying Promotions Seminar: The process perspective

Barbieri C.V. 32

Teaching Experience 2010 Harvard University Health Services Medical Grand Rounds:

Abnormal vaginal bleeding. Cambridge, MA. 2010, 2011,2013 Harvard Science and Technology Program. HST 070.

Lecture: Polycystic ovary syndrome. Boston, MA. 2010 American Congress of Obstetricians and Gynecologists.

District II. First Annual Martin Stone Lecture. Lecture: Oophorectomy at the time of hysterectomy. New York, NY.

2011 Center for Faculty Development and Diversity, Brigham and Women’s Hospital. Lecture: A chair’s view: advancing women in academic medical careers. Boston, MA

2011 Northwestern University, Department of Obstetrics and Gynecology, 30th Annual Resident and Fellow Research Day, 5th Annual Albert Gerbie Lecture. Presentation: One precious life: designing a fulfilling career. Chicago, IL.

2011 North Shore – Long Island Jewish University Hospital, Department of Obstetrics and Gynecology, Dr. Arnold Fenton Lecture. Presentation: Enhancing physician resilience. Manhasset, NY.

2011 Brigham and Women’s Hospital Center for Faculty Development and Diversity. Lecture: Demystifying promotions: Instructor to Assistant Professor. Boston, MA

2012 Harvard – MIT Health Sciences and Technology. HST 070. Lecture: WHO menstrual disorders. Boston, MA

2013 Harvard Vanguard Obstetrics and Gynecology, Quarterly Education Meeting. Lecture: PCOS- Why are endocrinologists trying to confuse us? Boston, MA.

2013 Council of University Chairs in Ob-Gyn Annual Meeting. Presentation: Preserving reproductive rights for women: our role and responsibility. New Orleans, LA.

2013 Pediatric and Adolescent Gynecology, Harvard Medical School, Presentation: “Is it PCOS?”, Boston MA.

2013 Obstetrical Society of Boston. Androgen Disorders in Adolescence: Is it PCOS? Boston, MA.

2014 Ob-Gyn Grand Rounds, Saint Elizabeth’s Hospital, “Menopause- 2014”. Boston, MA.

2014 Office Practice of Primary Care Medicine. Harvard Medical School. Workshop: Abnormal vaginal bleeding. Boston, MA.

2014 Update in Obstetrics and Gynecology. Harvard Medical School. Workshop: PCOS. Lectures: 1) Osteoporosis and 2) Hyperandrogensim/Polycystic Ovary Syndrome, Evaluation and Treatment.

2014 University of Pennsylvania, Obstetrics and Gynecology Grand Rounds. Presentation: Menopause Update 2014: Are we coming to the end of the estrogen-progestin era for HT? Philadelphia, PA.

33

2014 New England Fertility Society 25th Annual Meeting. Lecture: Update on PCOS. Newport RI.

2014 Brigham and Women’s Hospital. Department of Obstetrics and Gynecology Grand Rounds. Mortality and Menopause. Boston, MA.

2014 Harvard Science and Technology Program. HST 070. Lecture: Polycystic ovary syndrome. Boston, MA.

2015 Promotion from Associate Professor to Professor at Harvard Medical School with Zoe Fonseca-Kelly. Brigham and Women’s Hospital, Boston MA.

2015 Menopause Management. Office Practice of Primary Care Medicine 2015. Harvard Medical School. Boston MA

2015-2016 Androgen disorders in adolescents: Is it PCOS? Pediatric and Adolescent Gynecology, Boston Children’s Hospital. Boston MA

2015 Polycystic Ovary Syndrome: From Adolescence to Menopause. Grand Rounds. Emerson Hospital . Concord MA.

2015, 2016 Practice of Medicine Course, Patient Doctor II. Genitourinary and Gynecologic exam practicum. Faculty preceptor. Harvard Medical School. Boston MA.

2015 Update in Obstetrics and Gynecology. Harvard Medical School. Workshop: PCOS. Lectures: 1) Osteoporosis, 2015 and 2) Hyperandrogensim/Polycystic Ovary Syndrome, Evaluation and Treatment and 3) PCOS Workshop.

2016 Update in Obstetrics and Gynecology. Harvard Medical School. Workshop: PCOS. Lectures: 1) Osteoporosis, Breaking Bad in 2016 and 2) Hyperandrogensim/Polycystic Ovary Syndrome, Evaluation and Treatment and 3) PCOS Workshop.

2016 Objective Standardized Examination- Breast examination. Harvard Medical School.

2016 Reproductive health care for breast cancer survivors. St. Elizabeth’s Hospital Ob Gyn Grand Rounds., Boston, MA.

2016 On the shoulders of giants. A brief history of the Massachusetts General Hospital and Boston medicine. Massachusetts General Hospital Ob Gyn Grand Rounds. Boston MA.

2016 PCOS. University of Connecticut, Reproductive Endocrinology Rounds. Farmington CT.

2016 Reproductive health care for breast cancer survivors. Department of Obstetrics and Gynecology Grand Rounds. University of Connecticut. New Britain CT.

2016 Harvard Science and Technology. HST070. Menstrual dysfunction. Cambridge Massachusetts.

2017 Harvard Medical School. Pharmacology and Clinical Therapeutics. PHM350. Lecture: Contraceptive and Hormone Therapy Pharmacology.

Barbieri C.V. 34

35

Original Reports 1. Barbieri RL, Canick JA, Makris A, Todd RB, Davies IJ, Ryan KJ. Danazol

inhibits steroidogenesis. Fertil Steril. 1977; 28:809-13. 2. Barbieri RL, Canick JA, Ryan, KJ. Danazol inhibits steroidogenesis in the rat

testis in vitro. Endocrinology 1977; 101:1676-82. 3. Shane JM, Kates J, Barbieri RL, Todd RB, Davies IJ. Pituitary gonadotropin

responsiveness with danazol. Fertil Steril. 1978; 29:637-9. 4. Barbieri RL, Canick JA, Ryan KJ. Estrogen 2-hydroxylase: activity in rat

tissues. Steroids 1978; 32:529-38. 5. Barbieri RL, Lee H, Ryan KJ. Danazol binding to rat androgen,

glucocorticoid, progesterone and estrogen receptors: correlation with biological activity. Fertil Steril. 1979; 31:182-6.

6. Barbieri RL, Osathanondh R, Stillman RJ, Canick JA, Ryan KJ. Danazol

inhibits human adrenal 21- and 11-beta-hydroxylation. Steroids 1980; 35:251-63.

7. Barbieri, RL, Ryan KJ. Direct effects of medroxyprogesterone acetate (MPA)

and megestrol acetate (MGA) on rat testicular steroidogenesis. Acta Endocrinol. 1980; 94:419-25.

8. Stillman RJ, Fencl M, Schiff I, Barbieri RL, Tulchinsky D. Inhibition of

adrenal steroidogenesis by danazol in vivo. Fertil Steril. 1980; 33:401-6. 9. Barbieri RL, Morishita H, Ryan KJ, Fishman J, Naftolin F. Response of

serum prolactin to catechol estrogens in the immature rat. Fertil Steril. 1980; 34:391-3.

10. Barbieri RL, Canick JA, Ryan KJ. High-affinity steroid binding to rat testis

17-alpha-hydroxylase and human placental aromatase. J Steroid Biochem. 1981; 14:387-93.

11. Barbieri RL, Osathanondh R, Ryan KJ. Danazol inhibition of steroidogenesis

in the human corpus luteum. Obstet Gynecol 1981; 57(S):722-4. 12. Podlas J, Barbieri RL, Salzman R, Woodson J, Fuller AF. Toxic shock

syndrome occurring in the luteal phase of the menstrual cycle. Am J Obstet Gynecol. 1981; 141:225-7.

Barbieri C.V. 36

Original Reports (continued): 13. Barbieri RL, Ryan KJ. Danazol: Endocrine pharmacology and therapeutic

applications. Am J Obstet Gynecol. 1981; 141:453-63. 14. Barbieri RL, Evans S, Kistner RW. Danazol in the treatment of

endometriosis: analysis of 100 cases with a 4-year follow-up. Fertil Steril. 1982; 37:737-46.

15. Barbieri RL, Ryan KJ. Hyperandrogenism, insulin resistance, acanthosis

nigricans: a common endocrinopathy with unique pathophysiologic features. Am J Obstet Gynecol. 1983; 147:90-102.

16. Barbieri RL, Petro Z, Canick JA, Ryan KJ. Aromatization of 19-norethindrone

to ethinyl estradiol in human placental microsomes. J Clin Endocrinol Metab. 1983: 57:299-303.

17. Barbieri RL, Ryan KJ. Bromocriptine: endocrine pharmacology and

therapeutic applications. Fertil Steril. 1983; 39:727-41. 18. Barbieri RL, Makris A, Ryan KJ. Effects of insulin on steroidogenesis in

cultured porcine ovarian theca. Fertil Steril. 1983; 40:237-41. 19. Barbieri RL, Makris A, Ryan KJ. Insulin stimulates androgen accumulation

in incubations of human ovarian stroma and theca. Obstet Gynecol. 1984; 64:735-805.

20. Barbieri RL, Cooper DS, Daniels GH, Nathan D, Klibanski A, Ridgway EC.

Prolactin responses to thyrotropin-releasing hormone in patients with hypothalamic-pituitary disease. Fertil Steril. 1985; 43:66-73.

21. Barbieri RL, Randall RW, Saltzman DH. Diabetes insipidus occurring in a

patient with Sheehan's syndrome during a gonadotropin-induced pregnancy. Fertil Steril. 1985; 44:529-31.

22. Barbieri RL, Saltzman D, Phillippe M, Torday JS, Randall R, Frigoletto FD,

Ryan KJ. Elevated beta-human chorionic gonadotropin and testosterone in cord serum of male infants of diabetic mothers. J Clin Endocrinol Metab. 1985; 61:976-9.

23. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin

stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986; 62:904-10.

37

Original Reports (continued): 24. Barbieri RL, Niloff JM, Bast RC, Schaetzl E, Kistner RW, Knapp RC. Elevated

serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril. 1986; 45:630-4.

25. Saltzman DH, Barbieri RL, Frigoletto FD. Decreased fetal cord prolactin

concentration in diabetic pregnancies. Am J Obstet Gynecol. 1986; 154:1035-8.

26. Barbieri RL, Saltzman DH, Torday JS, Randall RW, Frigoletto FD, Ryan KJ.

Elevated concentrations of beta-subunit of human chorionic gonadotropin and testosterone in the amniotic fluid of gestations of diabetic mothers. Am J Obstet Gynecol. 1986; 154:1039-43.

27. Barbieri RL, Gochberg J, Ryan KJ. Nicotine, cotinine and anabasine inhibit

aromatase in human trophoblast in vitro. J Clin Invest. 1986; 77:1727-33. 28. Barbieri RL. CA-125 in patients with endometriosis. Fertil Steril. 1986;

45:767-9. 29. Barbieri RL, McShane PM, Ryan KJ. Constituents of cigarette smoke inhibit

human granulosa cell aromatase. Fertil Steril. 1986; 46:232-6. 30. Hill JA, Barbieri RL, Anderson DJ. Detection of T8 (suppressor/cytotoxic)

lymphocytes in human ovarian follicular fluid. Fertil Steril. 1987; 47:114-7. 31. Friedman AJ, Ravnikar VA, Barbieri RL. Serum steroid hormone profiles in

postmenopausal smokers and nonsmokers. Fertil Steril. 1987; 47:398-401. 32. Smith S, Ravnikar VA, Barbieri RL. Androgen and insulin responses to an

oral glucose challenge in hyperandrogenic women. Fertil Steril. 1987; 48:72-7.

33. Barbieri RL, York CM, Cherry ML, Ryan KJ. The effects of nicotine, cotinine

and anabasine on rat adrenal 11-beta-hydroxylase and 21-hydroxylase. J Steroid Biochem. 1987; 28:25-8.

34. Hill JA, Barbieri RL, Anderson DJ. Immunosuppressive effects of danazol in

vitro. Fertil Steril. 1987; 48:414-8. 35. Friedman AJ, Barbieri RL, Benacerraf B, Schiff I. Treatment of leiomyomata

with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist. Fertil Steril. 1987; 48:560-4.

Barbieri C.V. 38

Original Reports (continued): 36. Friedman AJ, Barbieri RL, Doubilet PM, Fine C, Schiff I. A randomized,

double-blind trial of a gonadotropin-releasing hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri. Fertil Steril. 1988; 49:404-9.

37. Barbieri RL, Smith S, Ryan KJ. The role of hyperinsulinemia in the

pathogenesis of ovarian hyperandrogenism. Fertil Steril. 1988; 50:197-212. 38. Barbieri RL, Hornstein MD, Rein MS, Ryan KJ. Rat leydig cell and granulosa

cell 17-ketosteroid reductase:subcellular localization and substrate specificity. Am J Obstet Gynecol. 1988; 159:1564-9.

39. Friedman AJ, Harrison-Atlas D, Barbieri RL, Benacerraf B, Gleason R, Schiff

I. Medical management of uterine leiomyomata: treatment with depot leuprolide: A gonadotropin releasing hormone agonist. Fertil Steril. 1989; 51:241-56.

40. Cramer DW, Harlow BE, Barbieri RL, Ng WG. Galactose-1-phosphate

uridyl transferase activity associated with age at menopause and reproductive history. Fertil Steril. 1989; 51:609-15.

41. Hornstein MD, Barbieri RL, McShane PM. The effects of previous ovarian

surgery on the follicular response to ovulation induction in an in vitro fertilization program. J Reprod Med. 1989; 34:277- 81.

42. Snow R, Barbieri RL, Frisch RA. Estrogen-2-hydroxylase activity and

menstrual function in elite oarswomen. J Clin Endocrinol Metab. 1989; 69:369-76.

43. Hornstein MD, Barbieri RL, Ravnikar VA, McShane PM. The effects of

baseline ovarian cysts on the clinical response to controlled ovarian hyperstimulation in an in vitro fertilization program. Fertil Steril 1989; 52:437-40.

44. Yeh J, Barbieri RL, Ravnikar VA. Ovarian hyperstimulation syndrome

associated with leuprolide suppression: a case report. J In Vitro Fertil. 1989; 6:261-3.

45. Yeh J, Barbieri RL, Friedman AJ. Inhibition of Leydig cell steroidogenesis by

nicotine and cotinine in vitro. J Steroid Biochem. 1989; 33:627-30. 46. Yeh J, Tien P, Barbieri RL. 24-hour urinary free cortisol in premenopausal

cigarette smokers and non-smokers. Fertil Steril. 1989; 52:1067-9.

39

Original Reports (continued): 47. Barbieri RL, Friedman AJ, Osathanondh R. Cotinine and nicotine inhibit

human adrenal 11-beta-hydroxylase in vitro. J Clin Endocrinol Metab. 1989; 69:1221-4.

48. Hankinson SE, London SJ, Chute CG, Barbieri RL, Jones L, Kaplan LA, Sacks

FM, Stampfer MJ. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem. 1989; 35:2313-6.

49. Hornstein MD, Gleason RE, Barbieri RL. A randomized-double-blind

prospective trial of two doses of gestrinone in the treatment of endometriosis. Fertil Steril 1990; 53:237-41.

50. Friedman AJ, Rein MS, Pandian MR, Barbieri RL. Fasting serum growth

hormone and insulin-like growth factor -I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo. Fertil Steril. 1990; 53:250-3.

51. Barbieri RL. Comparison of the pharmacology of nafarelin and danazol.

Am J Obstet Gynecol. 1990; 162:581-5. 52. Barbieri RL. Gonadotropin-releasing hormone agonists and estrogen-

progestogen replacement therapy. Am J Obstet Gynecol. 1990; 162:293-5. 53. Rein M, Barbieri RL, Greene M. High order multiple gestation associated

with the use of clomiphene citrate and human menopausal gonadotropins. Int J Fertil. 1990; 35:154-6.

54. Snow RC, Schneider JS, Barbieri RL. High dietary fiber and low saturated

fat intake among oligomenorrheic undergraduates. Fertil Steril. 1990; 54:632-37.

55. Friedman AJ, Lobel SM, Rein MS, Barbieri RL. Efficacy and safety

considerations in women with leiomyomata uteri treated with GnRH agonists: the estrogen threshold hypothesis. Am J Obstet Gynecol. 1990; 163:1114-9.

56. Zeigler T, Barbieri RL, Young LS, Ferrari-Baliviera E, Wilmore D. Androgen

and glucocorticoid response to human growth hormone following prolonged illness. Clin Endocrinol. 1991; 34:281-287.

57. Chalas E, Chumas J, Barbieri RL, Mann WJ. Nucleolar organizer regions in

endometriosis, atypical endometriosis, and clear cell and endometrioid carcinomas. Gynecol Oncol. 1991; 40:260-263.

Barbieri C.V. 40

Original Reports (continued): 58. Gerard EL, Snow RC, Kennedy DN, Frisch RE, Guimares A, Barbieri RL,

Sorenson AF, Rosen BR. MRI quantification of relative fatness and regional fat distribution in young women. AJR. 1991; 157:99-104.

59. Rein MS, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Morton CC.

Heterogenous cytogenetic abnormalities are associated with uterine leiomyomata. Obstet Gynecol. 1991; 77:923-926.

60. Barbieri RL, Gordon AMC. Hormonal therapy of endometriosis: the

estradiol target. Fertil Steril 1991; 56:820-822. 61. Salvini S, Stampfer MJ, Barbieri RL, Hennekens CH. Effects of age and

smoking on plasma DHEAS levels: a cross-sectional study in men. J Clin Endocrinol Metab. 1992; 74:139-143.

62. Frisch RE, Gerard EL, Snow R, Johnson L, Kennedy D, Barbieri RL, Rosen B.

Magnetic resonance imaging of body fat of athletes compared to controls, and the oxidative metabolism of estradiol Metabolism. 1992; 41:191-193.

63. Chalas E, Welshinger M, Engellener W, Chumas J, Barbieri RL, Mann WJ.

The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol. 1992; 166:974-977.

64. Lieberman E, Torday J, Barbieri RL, Cohen A, van Vunakis H, Weiss ST.

Association of intrauterine cigarette smoke exposure with indices of fetal lung maturation. Obstet Gynecol. 1992;79:564-70

65. Barbieri RL, Callery M, Perez SE. Directionality of menstrual flow: cervical

os diameter as a determinant of retrograde menstruation. Fertil Steril. 1992; 57:727-30.

66. Barbieri RL. Human ovarian 17-ketosteroid oxido-reductase: unique

characteristics of the granulosa-luteal cell and stromal enzyme. Am J Obstet Gynecol. 1992; 166:1117-1126.

67. Hornstein MD, Thomas PP, Gleason RE, Barbieri RL. Menstrual cyclicity of

CA-125 in patients with endometriosis. Fertil Steril 1992; 58:279-283. 68. Lobel SM, Yeh J, Barbieri RL. Acute adrenocorticotropin stimulation of

postmenopausal cigarette smokers and non-smokers: Effects on steroidogenesis. Fertil Steril. 1993; 59:229-231.

41

Original Reports (continued): 69. Barbieri RL, Ferracci A, Droesch JN, Rochelson BL. Ovarian torsion in a

premenopausal woman treated with tamoxifen for breast cancer. Fertil Steril. 1993; 59:459-460.

70. Hornstein MD, Orav J, Gleason RE, Haas ST, Friedman AJ, Rein MS, Hill JA,

Barbieri RL. The reproducibility of the revised AFS classification of endometriosis. Fertil Steril. 1993; 59:1015-21.

71. Frisch RE, Snow RC, Johnson L, Gerard B, Rosen B, Barbieri RL. Magnetic

resonance imaging of overall and regional body fat, estrogen metabolism and ovulation in athletes compared to controls. J Clin Endocrinol Metab 1993;77:471-477.

72. Barbieri RL, Dilena M, Chumas J, Rein MS, Friedman AJ. Leuprolide acetate

depot decreases the number of nucleolar organizer regions in uterine myomas. Fertil Steril. 1993; 60: 569-570.

73. Andersen J, Grine E, Ng CLY, Zhao K, Barbieri RL, Chumas J, Brink P.

Expression of connexin 43 in human myometrium and leiomyoma. Am J Obstet Gynecol 1993; 169:1266-76.

74. Rein MS, Barbieri RL, Welch W, Caufield J, Friedman AJ. The

concentrations of collagen-associated amino acids are higher in gonadotropin releasing hormone agonist treated uterine myomas. Obstet Gynecol 1993; 82:901-5.

75. Emanual RL, Robinson BG, Seely EW, Graves SW, Kohane I, Saltzman D,

Barbieri RL, Majzoub JA. Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestation. Clinical Endocrinol 1994; 40:257-62.

76. Barbieri RL, Gao X. 17-Hydroxysteroid dehydrogenase: enzyme activity

and mRNA species in choriocarcinoma cells. Gynecol Obstet Invest. 1994; 37:210-214.

77. Barbieri RL, Gao X, Frost RA. Phosphorylation of 17-hydroxysteroid

dehydrogenase in BeWo Choriocarcinoma cells. Am J Obstet Gynecol. 1994; 171:223-230.

78. Barbieri RL. Insulin stimulates androgen accumulation in incubations of

minced porcine theca. Gynecol Obstet Invest 1994; 37:265-269. 79. Hull ME, Barbieri RL. Nafarelin in the treatment of endometriosis: dosage

management. Gynecol Obstet Invest 1994; 37:263-264.

Barbieri C.V. 42

Original Reports (continued): 80. Droesch K, Barbieri, RL. Ovarian hyperstimulation syndrome associated

with the use of the gonadotropin releasing hormone agonist: leuprolide acetate. Fertil Steril. 1994; 62:189-190.

81. Cramer DW, Barbieri RL, Xu H, Reichardt JKV. Determinants of basal

follicle stimulating hormone levels in premenopausal women. J. Clin Endocrinol Metab. 1994; 79:1105-1109.

82. Cramer DW, Barbieri RL, Muto MG, Mather J, Woodruff T, Kelly A, Brucks

JP, Harlow BL. Characteristics of women with a family history of ovarian cancer II. Follicular phase hormone levels. Cancer. 1994; 74:1318-22.

83. Newcomer LM, Manson JE, Barbieri, RL, Hennekens CH, Stampfer MJ,

Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians: a prospective study. Am J Epidemiol 1994; 140:870-5.

84. Ginsburg ES, Walsh BW, Shea BF, Gao X, Gleason RE, Feltmate C, Barbieri

RL. The effect of acute ethanol ingestion on prolactin in menopausal women using estradiol replacement. Gynecol Obstet Invest. 1995, 39:47-49.

85. Ginsburg ES, Walsh BW, Gao X, Gleason RE, Feltmate C, Barbieri RL. The

effect of acute ethanol ingestion on estrogen levels in postmenopausal women using transdermal estradiol. J Soc Gynecol Invest 1995; 2:26-29.

86. Andersen J, DyReyes V, Barbieri RL, Coachman DM, Miksicek R.

Leiomyoma primary cultures have elevated transcriptional response to estrogen compared to autologous myometrial cultures. J Soc Gynecol Invest 1995; 2:542-551.

87. Ginsburg ES, Walsh BW, Shea BF, Gao X, Gleason RE, Barbieri RL. The

effects of ethanol on the clearance of estradiol in postmenopausal women. Fertil Steril 1995; 63:1227-30.

88. Barbieri RL, Gao X, Xu, H, Cramer DC. Effects of previous use of oral

contraceptives on early follicular phase follicle stimulating hormone. Fertil Steril 1995; 64:689-692.

89. Tanasijevic M. Ginsburg ES, Wybenga DR, Barbieri RL, Winkelman JW.

Total serum calcium reference intervals in post-menopausal outpatients. Gynecol Obstet Invest 1995; 39:266-270.

90. Frisch RE, Snow RC, Johnson LA, Gerard B, Rosen B, Erat K, Barbieri, RL.

Insulin response of women athletes in relation to body fat quantified by magnetic resonance imaging. Gynecol Obstet Invest 1995; 40:195-199.

43

Original Reports (continued): 91. Cramer DC, Harlow BL, Barbieri, RL. Cross-sectional and case-control

studies of smoking and early menopause. Maturitas 1995; 22:79-87. 92. Laufer MR, Floor AE, Parsons KE, Kuntz KM, Barbieri RL. Hormone testing

in women with adult onset amenorrhea. Gynecol Obstet Invest 1995; 40:200-203.

93. Laufer MR, Floor AE, Parsons KE, Kuntz KM, Barbieri RL, Friedman AJ.

Evaluation of hormonal testing in the screening for in vitro fertilization of women with tubal factor infertility. J Asst Repro Genetics 1995; 12:93-96.

94. Trad FS, Hornstein MD, Barbieri RL. A study of the cost effectiveness of in

vitro fertilization. J Asst Repro Genetics 1995; 12:418-421. 95. Laohaprasitiporn C, Barbieri RL, Yeh J. Induction of ovulation with the sole

use of clomiphene citrate in late-onset 21-hydroxylase deficiency. Gynecol Obstet Invest 1996; 41:224-226.

96. Cramer DW, Hornstein M, Ng WG, Barbieri RL. Endometriosis associated

with the N314D mutations of galactose-1-phosphate uridyl transferase. Mol Hum Reprod 1996; 2:149-152.

97. Ginsburg ES, Mello NK, Mendelson JH, Barbieri RL, Teoh SK, Rothman M,

Gao X, Sholar JW. Effects of alcohol intoxication on estrogens in postmenopausal women. JAMA 1996; 276:1747-51.

98. Ahmed MS, Barbieri RL. Reoperation rates for recurrent endometriomas

after surgical excision. Gynecol Obstet Invest 1996; 43:53-54. 99. Barbieri RL. Reduction in the size of uterine leiomyoma following

discontinuation of an estrogen-progestin contraceptive. Gynecol Obstet Invest 1997; 43:276-277.

100. Barbieri RL, Gao X. Presence of 17-hydroxysteroid dehydrogenase type 3 transcript in an ovarian Sertoli-Leydig cell tumor. Fertil Steril 1997;68:534-7.

101. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz

GA, Willett WC, Hunter DJ. Variation of the incidence of uterine leiomyomata according to age and race among premenopausal women. Obstet Gynecol 1997;90:967-73.

102. Martin KA, Hornstein M, Taylor AE, Hall JE, Barbieri RL. Exogenous gonadotropin stimulation is associated with increases in serum androgens in IVF-ET cycles. Fertil Steril 1997;68:1011-6.

Barbieri C.V. 44

Original Reports (continued): 103. Ginsburg ES, Gao X, Shea BF, Barbieri RL. The half-life of estradiol in

postmenopausal women. Gynecol Obstet Investigation 1998;45:45-48. 104. Rein MS, Powell WL, Walters FC, Weremowicz S, Cantor, RM, Barbieri RL,

Morton CC. Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol Hum Reprod 1998; 4:83-86.

105. Bohlke K, Cramer DC, Barbieri RL. The relation of luteinizing hormone

levels to body mass index in premenopausal women. Fertil Steril 1998;69:500-4.

106. Yanushpolsky EH, Best CL, Jackson KV, Clarke RN, Barbieri RL, Hornstein

MD. Effects of endometriomas on oocyte quality, embryo quality and pregnancy rates in in vitro fertilization cycles: a prospective, controlled study. J Genetics Assist Repro 1998;15:193-7.

107. Cramer DW, Liberman RF, Hornstein M, McShane P, Powers D, Li EY,

Barbieri RL. Basal hormone levels in women who use acetaminophen for menstrual pain. Fertil Steril 1998; 70:371-3.

108. Propst AM, Storti K, Barbieri RL. Lateral cervical displacement: An

association with endometriosis. Fertil Steril 1998; 70:568-570

109. Barbieri RL. Stenosis of the external cervical os: An association with endometriosis in women with chronic pelvic pain. Fertil Steril 1998; 70:571-3

110. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. JNCI 1998; 90:1292-9.

111. Marshall LM, Spiegelman D, Goldman MB, Manson JE, Colditz GA, Barbieri

RL, Stampfer MJ, Hunter DJ. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 1998; 70:432-9.

112. Laufer MR, Heerema AE, Parsons KE, Barbieri RL. Endosalpingiosis:

Clinical presentation and follow-up. Gynecol Obstet Invest 1998; 46:195-8.

113. Marshall JM, Spiegelman D, Manson JE, Goldman MD, Barbieri RL, Stampfer MJ, Willett WC, Hunter DJ. Risk of uterine leiomyomata among premenopausal women in relation to weight, weight gain and cigarette smoking. Epidemiology 1998;9:511-7.

45

Original Reports (continued):

114. Pardanani S, Barbieri RL, The gold standard for the surgical diagnosis of endometriosis: Visual findings or biopsy results. J Gynecol Techniques 1998; 4:121-124.

115. Pardanani S, Barbieri RL. Neurovascular complications of the lithotomy position: the four hour rule. J. Gynecol Techniques 1998; 4:143-148

116. Cramer DW, Powers DR, Oskowitz SP, Liberman RF, Hornstein MD, McShane PM, Barbieri RL. Gonadotropin releasing hormone agonist use in assisted reproduction cycles: The influence of long and short regimens on pregnancy rates. Fertil Steril 1999; 72:83-9

117. Harlow BL, Barbieri RL. Influence of education on risk of hysterectomy before age 45 years. Am J Epidemol 1999; 150:843-7

118. Barbieri RL, Propst AM. Physical examination findings in endometriosis: Uterosacral ligament abnormalities, lateral cervical displacement and cervical stenosis. J Gynecol Techniques 1999; 5:157-159

119. Atilano LC, Lee-Parritz A, Lieberman E, Cohen AP, Barbieri RL, Alternative methods of diagnosing gestational diabetes mellitus. Am J. Obstet Gynecol 1999; 181:1158-61

120. Michaud DS, Manson JE, Spiegelman D, Barbieri RL, Sepkovic DW, Bradlow HL, Hankinson SE. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one year period. Cancer Epidemiology, Biomarkers and Prevention 1999; 8:1059-64.

121. Cramer DW, Liberman RF, Powers DR, Hornstein MD, McShane PM, Barbieri, RL. Recent trends in assisted reproductive techniques and associated outcomes. Obstet Gynecol 2000; 95:61-6

122. Mantzoros CS, Cramer DW, Liberman RF, Barbieri RL. Serum and follicular fluid leptin levels during assisted reproductive cycles in normal women and in women with polycystic ovary syndrome. Human Reprod 2000; 15:539-44

123. Holmes MD, Spiegelman D, Willett WC, Manson JE, Hunter DJ, Barbieri RL,

Colditz GA, Hankinson SE. Dietary fat intake and endogenous steroid hormone levels in postmenopausal women. J Clin Oncology 2000; 18:3668-76.

124. Cramer DW, Petterson KSI, Barbieri, Huhtaniemi IT. Reproductive hormones, cancers and conditions in relation to a common genetic variant of luteinizing hormone. Human Reproduction 2000; 15: 2103-7.

Barbieri C.V. 46

Original Reports (continued):

125. Sussman AJ, Barbieri, RL, Brennan TA. Global capitation at the women’s health referral center: the challenge of patient selection. Obstet Gynecol 2000; 96:1018-2.

126. Barbieri, RL. Induction of ovulation in infertile women with hyperandrogenism

and insulin resistance. Am J Obstet Gynecol 2000; 183: 1412-8. 127. Watt AH, Legedza ATR, Ginsburg ES, Barbieri, RL, Clarke RN, Hornstein MD. The

prognostic value of age and follicle stimulating hormone levels in women over forty years of age undergoing in vitro fertilization. J Assisted Reprod Genetics 2000; 17: 264-8.

128. Bo-Abbas YY, Martin KA, Liberman RF, Cramer DW, Barbieri, RL. Serum and

follicular fluid hormone levels during in vitro fertilization after short or long courses of GnRH agonist treatment. Fertil Steril 2001; 75: 694-99.

129. Lucero J, Harlow BL, Barbieri RL, Sluss P, Cramer DW. Early follicular phase

hormone levels in relation to patterns of alcohol, tobacco and coffee use. Fertil Steril 2001; 76:723-9.

130. Barbieri RL. The initial fertility consultation: recommendations concerning

cigarette smoking, body mass index, alcohol and caffeine consumption. Am J Obstet Gynecol 2001; 185:1168-73.

131. Cramer DW, Barbieri RL, Fraer AR, Harlow BL. Determinants of early follicular

phase gonadotropin and estradiol levels in women of late reproductive age. Human Reprod 2002; 17:221-7.

132. Harlow BL, Missmer SA, Cramer DW, Barbieri RL. Does tubal sterilization

influence the subsequent risk of menorrhagia or dysmenorrhea. Fertil Steril 2002; 77:754-60.

133. Barbieri RL. Metformin for the treatment of the polycystic ovary syndrome. Obstet

Gynecol 2003; 10:785-93. 134. Cramer DW, Sluss PM, Powers DR, McShane P, Ginsburg ES, Hornstein MD, Vitonis AF, Barbieri RL. Serum prolactin and TSH in in-vitro fertilization population: Is there a link between fertilization and thyroid function. J Assisted Repro Genetics 2003;20:210-215. 135. Barbieri RL. Geographic distribution of obstetrics and gynecology resident training

positions. Obstet Gynecol 2004; 103:1317-20.

47

Original Reports (continued): 136. Page JH, Colditz GA, Rifai N, Barbieri RL, Willett WC, Hankinson SE. Plasma

adrenal androgens and risk of breast cancer in premenopausal women. Cancer Epidemiol Biomarkers Prev 2004; 13:1032-6.

137. Barbieri RL. Population density and teen pregnancy. Obstet Gynecol 2004; 104:

741-4. 138. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Malspeis S,

Willett WC, Hunter DJ. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol 2004; 104:965-74.

139. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Willett WC,

Hunter DJ. The incidence of laparoscopically-confirmed endometriosis by demographic, anthropomorphic and lifestyle factors. Am J Epidemiol 2004; 160:784-96.

140. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Michels KB,

Willett WC, Hunter DJ. In utero exposures and the incidence of endometriosis. Fertil Steril 2004; 82:1501-8

141. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen,

androgen and progesterone concentrations and the risk of breast cancer among postmenopausal women. J Natl Cancer Inst 2004; 96:1856-65.

142. Barbieri RL, Sluss PM, Powers RD, McShane P, Vitonis A, Ginsburg E,

Cramer DC. Association of age and body mass index with serum testosterone in cycling women undergoing in vitro fertilization. Fertil Steril 2005; 83:302-8.

143. Viswanathan AN, Feskanich D, DeVivo I, Hunter DJ, Barbieri RL, Rosner R,

Colditz GA, Hankinson SE. Smoking and the risk of endometrial cancer: results from the Nurses Health Study. Int J Cancer 2005; 114:996-1001.

144. Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson

SE. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. J Natl Cancer Inst 2005; 97:595-602.

145. Barbieri RL, Michel KB, Anastos L. Economic factors and the percentage of residency positions filled by United States medical graduates. Obstet Gynecol 2005; 106:581-584.

Barbieri C.V. 48

Original Reports (continued):

146. Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL, Colditz GA, Willett WC, Hankinson SE. Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev 2005; 14:2147-2153.

147. Lifford K, Curhan GC, Hu FB, Barbieri RL, Grodstein F. Type 2 diabetes mellitus

and the risk of developing urinary incontinence. J Am Geriatrics Soc 2005; 53:1851-1857.

148. Barbieri RL. Professional liability payments in obstetrics and gynecology. Obstet

Gynecol. 2006; 107:578-581. 149. Missmer SA, Spiegelman D, Hankinson SE, Malspeis S, Barbieri RL, Hunter DJ.

Natural hair color and the incidence of endometriosis. Fertil Steril 2006; 85:866-870. 150. Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN,

Hankinson SE. Reproducibility of plasma steroid hormones, prolactin and insulin-like growth factor levels among premenopausal women over a 2-3 year period. Cancer Epidemiol Biomarkers Prev 2006; 15:972-978

151. Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, Barbieri RL, Hankinson SE. The association of plasma dehydroepiandrostrone and dehydroepiandrostrone sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15:967-71.

152. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M,

Hankinson, SE. Endogenous steroid hormone concentrations and risk of breast cancer among predominantly premenopausal women. J Natl Cancer Inst 2006; 98:1406-15.

153. Tworoger SS, Eliassen AH, Missmer SA, Baer H, Rich-Edwards J, Michels K, Barbieri RL, Dowsett M, Hankinson, SE. Birth weight and body size throughout life in relation to sex hormones and prolactin concentrations in women. Cancer Epidemiol Biomarkers Prev 2006; 15:2494-501.

154. Barbieri RL, Tesoro M, Frigoletto FD. Twin goals: Professional development and improved patient care. Obstet Gynecol 2007; 109:435-40.

155. Tworoger SS, Missmer SA, Eliassen AH, Barbieri RL, Dowsett M, Hankinson, SE.

Physical activity and inactivity in relation to sex hormones, prolactin and insulin-like growth factor concentrations in premenopausal women. Cancer Causes Control 2007; 18:743-52.

49

Original Reports (continued): 156. Fung TT, Hu FB, Barbieri RL, Willett WC, Hankinson SE. Dietary patterns, the

alternate healthy eating index and plasma sex hormone concentrations in postmenopausal women. Int J Cancer 2007; 121:803-9.

157. Barbieri RL. Update in female reproduction: A life-cycle approach. J Clin

Endocrinol Metab 2008 93:2439-46.

158. Abusief ME, Missmer SA, Barbieri RL, Jain T, Hornstein MD. Geographic distribution of reproductive endocrinology and infertility fellowships in the United States. Fertil Steril 2009; 91:1636-1941.

159. Danforth KN, Eliassen AH, Tworoger SS, Missmer SA, Barbieri RL, Rosner BA, Colditz GA, Hankinson SE. The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women. Int J Cancer 2010; 126:199-207.

160. Levison JH, Barbieri RL, Katz JT, Loscalzo J. Clinical problem solving: hard to conceive. N Engl J Med 2010; 363:965-70.

161. Missmer SA, Chavarro JE, Malspeis S, Bertone-Johnson ER, Hornstein MD, Spiegelman D, Barbieri RL, Willett WC, Hankinson SE. A prospective study of dietary fat consumption and endometriosis risk. Human Reproduction 2010; 26: 1528-35.

162. Eliassen AH, Spiegelman D, Barbieri RL, Xu X, Keefer LK, Veenstra T, Willett WC, Hankinson SE, Ziegler RG. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res 2012; 72:696-706.

163. Meldrum DR, Chang RJ, Giudice LC, Balasch J, Barbieri RL. Role of decreased androgens in ovarian response to stimulation in older women. Fertil Steril 2013; 99: 5-11. 164. Fortner RT, Eliassen AH, Spiegelman D, Willett WC, Barbieri RL, Hankinson SE.

Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses’ Health Study II. Breast Cancer Res. 2013; 15 (2) epub. March 6, 2013.

165. Farland LV, Missmer SA, Rich-Edwards J, Chavarro JE, Barbieri RL, Grodstein F.

Use of fertility treatment modalities in a large United States cohort of professional women. Fertil Steril 2014; 101: 1705-10.

Barbieri C.V. 50

165. Prescott J, Farland L, tobias DK, Gaskins AJ, Spiegelman D, Charvarro JE, Rich-Edwards JW, Barbieri RL, Missmer SA. A prospective cohort study of endometriosis and subsequent risk of infertility. Human Reprod 2016; 31: 1475-82.

166. Mu F, Eliassen AH, Hankinson SE, Tworoger SS, Barbieri RL, Dowsett M, Pollak

MN, Missmer SA. Menstrual cycle characteristics in relation to plasma steroid hormone, prolactin and growth factor concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev 2015

167. Mu F, Eliassen AH, Hankinson SE, Barbieri RL, Missmer SA. Endogenous steroid

hormone concentrations and risk of endometriosis in the Nurses Health Study II. 2015 (Submitted).

51

Reviews

1. Kistner RW, Barbieri RL, Evans S. Endometriosis - 1984. In: Pitkin RM, Zlatnik FH, eds. Year Book of Obstetrics and Gynecology. Chicago: Year Book Medical Publishers,1984;pp.365-80.

2. Barbieri RL, Kistner RW. Hormonal therapy of endometriosis. In: Raynaud

JP, Ojasoo T, Martini L, eds. Medical Management of endometriosis. New York: Raven Press, 1984; pp. 27-40.

3. Barbieri RL, Ryan KJ. Medical therapy for endometriosis: endocrine

pharmacology. Semin Reprod Endocrinol. 1986; 3:339-52.

4. Barbieri RL, Kistner RW. Endometriosis. In: Kistner RW, ed. Gynecology: Principles and Practice. Chicago: Year Book Medical Publishers, 1986; pp.393-414.

5. Barbieri RL. Steroid therapy. In: Kistner RW, ed. Gynecology: Principles and Practice. Chicago: Year Book Medical Publishers, 1986; pp. 551-64.

6. Barbieri RL. Introducing the HAIR-AN syndrome. Masters Obstet Gynecol. 1986; 2:8-16.

7. Schiff I, Barbieri RL, Ryan KJ. Hyperandrogenism: ruling out the ominous.

Masters Obstet Gynecol. 1986; 2:20-2.

8. Barbieri RL. Citation analysis for the journal Fertility and Sterility. Fertil Steril. 1986; 45:892-3.

9. Barbieri RL, Hornstein M. Medical therapy for endometriosis. In: Wilson E,

ed. Endometriosis. New York: Alan R. Liss, 1987; pp.111-40.

10. Barbieri RL. CA-125 and endometriosis. In: Bruhat MP, ed. Contributions to Gynecology and Obstetrics. Vol. 16. Endometriosis. Switzerland: Karger, Basel, 1987.

11. Barbieri RL. New therapy for endometriosis. N Eng J Med. 1988; 318:512-3.

12. Hornstein MD, Barbieri RL. Endocrine therapy of endometriosis: danazol

and the synthetic progestins. In: Barbieri RL, Schiff I, eds. Reproductive Endocrine Therapeutics. New York: Alan R. Liss, 1988; pp.127-54.

13. Wah R, Barbieri RL. Contraceptive steroids. In: Barbieri RL, Schiff I, eds.

Reproductive Endocrine Therapeutics. New York: Alan R. Liss, 1988; pp.351-90.

Barbieri C.V. 52

Reviews (continued):

14. Friedman AJ, Barbieri RL. Leuprolide acetate: applications in gynecology. Curr Probl Obstet Gynecol Fertil. 1988; 11:207-44.

15. Barbieri RL, Hornstein MD. Hyperinsulinemia and ovarian hyperan-

drogenism: cause and effect. Endocrinol Metab Clin North Am. 1988; 17:685-703.

16. Barbieri RL. Endometriosis. Curr Probl Obstet Gynecol Fertil. 1989; 12:1-31.

17. Barbieri RL. Common problems in office gynecology: vaginitis and

abnormal pap smears. Mod Med. 1989; 57:50-5.

18. Yeh J, Barbieri RL. Effects of smoking on steroid production and metabolism and on estrogen related disease. Seminars Repro Endocrinol. 1989; 7:326-34.

19. Barbieri RL, Hornstein MD. Endometriosis. In: Ryan KJ, ed. Gynecology:

Principles and Practice. Chicago: Year Book Medical Publishers, 1989; pp.320-48.

20. Berkowitz RS, Barbieri RL. The ovary. In: Ryan KJ, ed. Gynecology:

Principles and Practice. Chicago: Year Book Medical Publishers, 1989; pp.256-304.

21. Ryan KJ, Barbieri RL. The menstrual cycle. In: Ryan KJ, ed. Gynecology:

Principles and Practice. Chicago: Year Book Medical Publishers, 1989; pp.15-62.

22. Barbieri RL. Danazol: molecular, endocrine and clinical pharmacology. In:

Chadha DR, Buttram V, eds. Current Concepts in Endometriosis. New York: Alan R. Liss, 1989, pp. 241-52.

23. Barbieri RL. The role of adipose tissue and hyperinsulinemia in the

development of hyperandrogenism in women. In Frisch R. ed. Adipose Tissue and Reproduction. Karger, Basel. 1989; pp.42-57.

24. Barbieri RL. Endometriosis 1990. Current treatment approaches. Drugs.

1990; 39:1-9.

25. Barbieri RL. Etiology and epidemiology of endometriosis. Am J Obstet Gynecol. 1990; 162:565-7.

53

Reviews (continued): 26. Barbieri RL. Danazol as a treatment of endometriosis. In: Rock J, Thomas E.

Modern approaches to endometriosis. MTP Press Limited, Lancaster, 1990; pp.239-256.

27. Barbieri RL. Management of hot flashes in the endometriosis patient: the

estrogen threshold theory. Menopause Management 1990; 3:9-11.

28. Barbieri RL. Polycystic ovary syndrome: Current Approaches. Dialogues in Contraception 1990; 3:4-7.

29. Canick JA, Barbieri RL. The effect of smoking on hormone levels in vivo and

steroid hormone biosynthesis in vitro. In: Wald N, Baron J. Smoking and Hormone Related Disorders. Oxford Medical Publishers 1990; pp.208-218.

30. Barbieri RL. Treatment of endometriosis with the GnRH-agonists. In:

Barbieri RL, Friedman AJ, eds. GnRH Analogs: Applications in Gynecology. New York Elsevier, 1990; pp.63-76.

31. Barbieri RL, Friedman AJ. Gonadotropin releasing hormone agonists and

estrogen-progestogen replacement therapy: the estrogen threshold hypothesis. In: Barbieri RL, Friedman AJ, eds. GnRH Analogs: Applications in Gynecology. New York: Elsevier, 1990; pp.77-90.

32. Barbieri RL. Hyperandrogenism: Treatment with GnRH agonists. In:

Barbieri RL, Friedman AJ, eds. GnRH Analogs: Applications in Gynecology. New York: Elsevier, 1990; pp.137-146.

33. Barbieri RL. Treatment of the premenstrual syndrome with GnRH agonists.

In: Barbieri RL, Friedman AJ, eds. GnRH Analogs: Applications in Gynecology. New York: Elsevier, 1990; pp.147-153.

34. Barbieri RL. Hyperandrogenic disorders. Clin Obstet Gynecol 1990; 33:640-

654.

35. Barbieri RL. Endometriosis 1990. Current Treatment Approaches. Current Therapeutics 1990; 31:71-81.

36. Barbieri RL. Gonadotropin-releasing hormone agonists and estrogen-

progestogen replacement therapy. Ob-Gyn Digest 1990;10:21-22.

37. Barbieri RL. Polycystic ovarian disease. Annual Review of Medicine 1991; 42:199-204.

Barbieri C.V. 54

Reviews (continued):

38. Barbieri RL. Radioimmunoassay for reproductive endocrine and fertility services. J Clin Immunoassay 1991; 14:33-36.

39. Barbieri RL. Hyperandrogenism: New insights into diagnosis and therapy.

Current Opinion in Obstetrics and Gynecology 1991; 3:316-325.

40. Barbieri, RL. Infertility aspects of endometriosis. In Droegemueller W, Sciarra JJ, Eds. Gynecology and Obstetrics. Philadelphia: Lippincott. 1991; Vol V; Chapter 59:1-17.

41. Barbieri RL. Critical drug appraisal: Nafarelin. Drug Therapy 1991; 21:23-

32.

42. Barbieri RL, Yeh J, Ravnikar VA. GnRH agonists and ovarian hyperstimulation. Fertil Steril 1991; 56:376.

43. Barbieri RL. Gonadotropin-releasing hormone agonist and estrogen-

progestogen replacement therapy. Am J Obstet Gynecol 1991; 165:1156-1157.

44. Barad D, Barbieri RL, Paulson S. Hirsutism. ACOG Update 1991; 16:1-10.

45. Barbieri RL. Endocrinology of the female. In: Kelley WN, ed. Textbook of Internal Medicine. Philadelphia: J.B. Lippincott 1992; pp 2011-2013.

46. Barbieri RL. Approach to menstrual disorders and galactorrhea. In: Kelley

WN, ed. Textbook of Internal Medicine. Philadelphia: J.B. Lippincott 1992; pp 2091-2092.

47. Barbieri RL. Approach to the patient with androgen excess. In: Kelley WN,

ed. Textbook of Internal Medicine. Philadelphia: J.B. Lippincott 1992; pp 2092-2094.

48. Barbieri RL. Approach to infertility in the female. In: Kelly WN, ed.

Textbook of Internal Medicine. Philadelphia: J.B. Lippincott 1992; pp 2094-2095.

49. Barbieri RL. Approach to sexual dysfunction in the female. In: Kelley WN,

ed. Textbook of Internal Medicine. Philadelphia: J.B. Lippincott 1992; pp 2097-2098.

50. Barbieri RL. Hormonal therapy of endometriosis. Infertility and

Reproductive Medicine Clinics of North America 1992; 3:187-200.

55

Reviews (continued):

51. Barbieri RL. Clinical applications of GnRH and its analogues. Trends Endocrinol Metab 1992; 3:30-34.

52. Barbieri RL. Endometriosis. In Rakel RE, ed. Conn's Current Therapy.

Philadelphia: W.B. Sanders, 1992; pp 1004-1006.

53. Barbieri RL. Effects of insulin on ovarian steroidogenesis. In: Dunaif A, Givens JR, Hazeltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Boston: Blackwell Scientific Publications 1992; pp 249-264.

54. Barbieri RL. Hormone treatment of endometriosis: the estrogen threshold

hypothesis. Am J Obstet Gynecol 1992; 166:740-745.

55. Barbieri RL, Diamond MP, Friedman AJ. Uterine Myomas: Pathobiology and Treatment. ACOG Update 1992; 17:1-10.

56. Barbieri RL. Estradiol target levels in treating endometriosis. Fertil Steril

1992;57:1361-62.

57. Barbieri RL. Hyperandrogenism: New insights into etiology, diagnosis and therapy. Current Opinion Obstet Gynecol 1992; 4:372-379.

58. Barbieri RL. Visual diagnosis of endometriosis - Reliability?. Fertil Steril

1992; 58:221-222.

59. Barbieri RL, Andersen J. Uterine leiomyomas: The somatic mutation theory. Seminars Reproductive Endocrinology 1992; 10:301-309.

60. Barbieri RL. Use of GnRH agonists in endometriosis. Infertility

Reproductive Medicine, Clinics North America 1993; 4:21-34.

61. Barbieri RL. Physiology of the normal menstrual cycle. In Smith S, Schiff I. eds. Modern Management of Premenstrual Syndrome. New York: Norton, 1993; pp 34-45.

62. Barbieri RL. Gonadotropin Releasing Hormone Agonists: Treatment of

Endometriosis. Clin Obstet Gynecol 1993; 36:636-641

63. Barbieri RL. Some genetic syndromes associated with hyperandrogenism. Contemporary Ob-Gyn 1994; 39:35-48.

64. Polan ML, Barbieri RL, Schmidt-Sarosi C. GnRH in gynecology. ACOG

Update 1994; 19:1-10.

Barbieri C.V. 56

Reviews (continued):

65. Barbieri RL, Hodgen GD, Murphy AA. RU-486. ACOG Update 1994; 20:1-10.

66. Barbieri RL. Hyperandrogenism, insulin resistance and acanthosis

nigricans, 10 years of progress. J. Reprod Medicine 1994; 39:327-336.

67. Barbieri RL. Clinical aspects of the hyperandrogenism - insulin resistance - Acanthosis Nigricans Syndrome. Seminars Repro Endocrinol 1994, 12:26-31.

68. Barbieri RL. Hyperandrogenism. In Willett GD. ed. Laboratory Testing in

Ob-Gyn . Boston: Blackwell, 1994; pp133-138.

69. Barbieri RL. Gonadotropin releasing hormone analogues for contraception. In Corson L, Derman RJ. Tyrer LB eds. Fertility Control London Ontario: Golden Publishers 1994; 247-257.

70. Barbieri RL. The Maternal Adenohypophysis. In Tulchinsky D, Little AB,

eds. Maternal-Fetal Endocrinology. Philadelphia W.B. Saunders 1994; 119-131.

71. Barbieri RL. Thyroid Disease - Often Overlooked. Audio Digest. 1994;

41:22.

72. Barbieri RL. Endometriosis: Medical Therapy. In: Keye W, Chang RJ, Rebar R, Soules M. Eds. Infertility: Evaluation and Treatment. Philadelphia. W.B. Saunders 1994; 509-516.

73. Rein MS, Barbieri RL, Friedman AJ. Progesterone: A critical role in the

pathogenesis of uterine myomas. Am J Obstet Gynecol 1995; 172:14-8.

74. Barbieri RL. Hyperandrogenic chronic anovulation. ACOG Technical Bulletin. 1995; 202:1-8.

75. Daniels GH, Barbieri RL. Clinical perspectives on postpartum thyroiditis.

Thyroid Update. 1995; 8:1-7.

76. Barbieri RL. Applications of gonadotropin releasing-hormone analogues in gynecology. In Nichols DH, Sweeney PF, eds. Ambulatory Gynecology. JB Lippincott. 1995; 164-178.

77. Barbieri RL. Hyperandrogenism. In Wallach EE, Zacur HA eds.

Reproductive Medicine and Surgery. St. Louis. Mosby. 1995; 209-229.

57

Reviews (continued):

78. Andersen J, Barbieri RL. Abnormal gene expression in uterine leiomyomas. J Soc Gynecol Invest 1995; 2:663-672.

79. Barbieri RL, Ryan KJ. The menstrual cycle. In: Ryan KJ, Berkowitz RS,

Barbieri RL eds. Kistner's Gynecology: Principles and Practice. St. Louis: Mosby 1995; pp 11-49.

80. Hornstein MD, Barbieri RL. Endometriosis. In: Ryan KJ, Berkowitz RS,

Barbieri RL eds. Kistner's Gynecology: Principles and Practice. St. Louis: Mosby 1995; pp 251-277.

81. Rice LW, Barbieri RL. The Ovary. In: Ryan KJ, Berkowitz RS, Barbieri RL

eds. Kistner's Gynecology: Principles and Practice. St. Louis: Mosby 1995; pp 187-223.

82. Barbieri RL. Infertility aspects of endometriosis. In Sciarra JJ Ed.

Gynecology and Obstetrics. Philadelphia: Lippincott-Raven 1996; Chapter 59, pp 1-18.

83. Barbieri RL, Lindsay R, Chang RJ, Lobo RA. Osteoporosis: Diagnosis,

treatment, monitoring. APGO Educational Series on Women’s Health Issues. MedEd. 1996; pp. 1-45.

84. Barbieri RL. Medical treatment of infertility associated with minimal to mild

endometriosis. Int J Fertil 1996;41:393-396.

85. Barbieri RL, Hill JA. Ten steps to writing a research proposal. Fertil Steril 1996;66:690-692.

86. Barbieri RL, Walsh B. Toward a better hysterectomy: maximization of

quality and minimization of resource utilization. J Gynecol Techniques. 1996;2:173-175.

87. Barbieri RL. Approach to menstrual disorders and galactorrhea. In Kelly

WN. Textbook of Internal Medicine. Philadelphia. Lippincott-Raven. 1997; Chapter 396, pp 2145-2148.

88. Barbieri RL. Approach to the patient with virilization. In Kelly WN.

Textbook of Internal Medicine. Philadelphia. Lippincott-Raven. 1997; Chapter 397, pp 2148-2149

89. Barbieri RL. Approach to sexual dysfunction in the female. In Kelly WN.

Textbook of Internal Medicine. Philadelphia. Lippincott-Raven. 1997; Chapter 400, pp 2153-2154.

Barbieri C.V. 58

Reviews (continued): 90. Barbieri RL. Endocrinology of the female. In Kelly WN. Textbook of Internal

Medicine. Philadelphia. Lippincott-Raven. 1997; Chapter 412, pp 2230-2232. 91. Barbieri RL, Aronne LJ, Gnatuk C, Ling FW, Pi-Sunyer X, White JV. Obesity

in Women APGO Educational Series of Women’s Health Issues. CTI, 1997, pp 1-27.

92. Barbieri RL. Primary gonadotropin-releasing hormone agonist therapy for

suspected endometriosis: a nonsurgical approach to the diagnosis and treatment of chronic pelvic pain. Am J Managed Care. 1997;3:285-290.

93. Barbieri RL, Cohen LS, Ling FW, Nemeroff CB, Yonkers KA. Depressive

disorders in women: diagnosis, treatment and monitoring. APGO Education Series on Women’s Health Issues. 1997;pp1-24.

94. Barbieri RL, Klibanski A, LeBoff MS. Osteoporosis. ACOG Update 1997;23:1-

12. 95. Barbieri RL. Danazol in the treatment of endometriosis. In Diamond MP,

Osteen KG. Ed. Endometrium and Endometriosis. Malden, MA. Blackwell Publishers, 1997; Chapter 25, pp 196-201.

96. Barbieri RL. Endometriosis and the estrogen threshold theory. J Repro

Medicine 1998; 43:287-92.

97. Barbieri RL. Osteoporosis. American College of Obstetricians and Gynecologists Educational Bulletin 1998; 246:1-13.

98. Barbieri RL. Seven steps to the effective treatment of osteoporosis in your

practice. Contemporary Ob-Gyn 1998; 43:30-50. 99. Barbieri RL, Schattman GL, Scialli AR, Surrey ES. Strategies for managing

endometriosis. OBG Management 1998; 12:1-5(S). 100. Barbieri RL, Carver J, Hill M, Rebar RW, Seltzer VL. Cardiovascular disease

in women. Association of Professors of Gynecology and Obstetrics, Education Series on Women’s Health Issues. 1998, pp 1-30.

101. Barbieri RL. A step-by-step approach to osteoporosis treatment. Patient

Care 1998; 32:138-152 102. Barbieri RL. Disorders of the uterus. Praecis-Gynecology. American

College of Obstetricians and Gynecologists. 1998; pp 34-40.

59

Reviews (continued): 103. Barbieri RL. Abdominal myomectomy is a safe and effective treatment for

uterine leiomyomata. J Gynecol Techniques 1998; 4:85-7. 2148-2149. 104. Barbieri RL. The Breast. In: Yen SSC, Jaffe RB, Barbieri RL,Eds.

Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. WB Saunders, Philadelphia. 1999; pp 284-300.

105. Barbieri RL. Infertility. In: Yen SSC, Jaffe RB, Barbieri RL,Eds. Reproductive

Endocrinology: Physiology, Pathophysiology and Clinical Management. WB Saunders, Philadelphia. 1999; pp 562-593

106. Barbieri, RL. Assisted Reproductive Technology. In: Yen SSC, Jaffe RB,

Barbieri RL, Eds. Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. WB Saunders, Philadelphia. 1999; pp. 594-621

107. Barbieri RL. Endocrine Disorders During Pregnancy. In: Yen SSC, Jaffe RB,

Barbieri RL; Eds Reproductive Endocrinology: Pathophysiology and Clinical Management. WB Saunders, Philadelphia. 1999; pp. 785-811

108. Barbieri, RL. Endometriosis and adenomyosis. In Fraser IS, Jansen RPS,

Lobo RA, Whitehead MI. (Eds) Estrogens and Progestogens. Churchill Livingstone, London 1998; pp 455-470.

109. Surrey ES, Add-Back Consensus Working Group. Add-back therapy and

gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Fertil Steril 1999; 71:420-24.

110. Propst AM, Barbieri RL. Endometriosis- back to basics with the physical

examination. Fertil Steril 1999; 71:777-8. 111. Barbieri RL. Osteoporosis in Holzman GB, Rinehart RD, Dunn LJ (Eds). Precis. Primary and Preventive Care. American College of Obstetricians and

Gynecologists. Washington D.C. 1999 pp 192-198. 112. Barbieri RL. The Safety of third generation oral contraceptives J. Clin

Endocrinol Metab 1999;84:1822-23. 113. Barbieri RL. Amenorrhea. In Barbieri RL, Berga SL, DeCherney AH, Hade J,

Sheets EE. Eds. Gynecology in Primary Care: A Step by Step Approach.Scientific American Medicine. New York 1999;pp 1-6

Barbieri C.V. 60

Reviews (continued): 114. Barbieri RL. Chronic Pelvic Pain and Endometriosis. In Barbieri RL, Berga

SL, DeCherney AH, Hade J, Sheets EE. Eds. Gynecology in Primary Care: A Step by Step Approach. Scientific American Medicine. New York 1999; pp 59-62.

115. Barbieri RL. Vaginitis and vaginal discharge. In Barbieri RL, Berga SL,

DeCherney AH, Hade J, Sheets EE. Eds. Gynecology in Primary Care: A Step by Step Approach. Scientific American Medicine. New York 1999; pp 63-67.

116. Barbieri RL. Uterine Leiomyomas. In Barbieri RL, Berga SL, DeCherney

AH, Hade J, Sheets EE. Eds. Gynecology in Primary Care: A Step by Step Approach. Scientific American Medicine. New York 1999; pp 79-82.

117. Barbieri RL. Incontinence and the Overactive Bladder. In Barbieri RL,

Berga SL, DeCherney AH, Hade J, Sheets EE. Eds. Gynecology in Primary Care: A Step by Step Approach. Scientific American Medicine. New York 1999; pp 97-99.

118. Barbieri RL, Ryan KJ. The Menstrual Cycle. In Ryan KJ, Berkowitz RS,

Barbieri RL, Dunaif A., Eds. Kistner’s Gynecology and Women’s Health. Mosby-Saunders. 1999;pp 23-57.

119. Rein MS, Barbieri, RL. The Infertile Couple. In Ryan KJ, Berkowitz, RS,

Barbieri RL, Dunaif A., Eds. Kistner’s Gynecology and Women’s Health. Mosby-Saunders. 1999;pp 325-372.

120. Hornstein MD, Barbieri RL. Endometriosis. in Ryan KJ, Berkowitz RS,

Barbieri RL, Dunaif A., Eds. Kistner’s Gynecology and Women’s Health. Mosby-Saunders. 1999; pp 492-518.

121. Barbieri RL, Hornstein, MD. Assisted Reproduction-In Vitro Fertilization

success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin releasing hormone analogues. Endocrine Reviews 1999; 20: 249-252.

122. Barbieri, RL, Legro RS, Lewis SJ, Walsh BW, Welty FK. Managing

hyperlipidemia in women. Association of Professors of Gynecology and Obstetrics Educational Series on Women’s Health Issues. 1999; pp1-29.

123. Barbieri RL. Primary gonadotropin releasing hormone against therapy for

suspected endometriosis: a nonsurgical approach to the diagnosis and treatment of chronic pelvic pain. Hormone Therapy in Obstet Gynecol 1999; 4:19-24.

61

Reviews (continued): 124. Berga SL, Barbieri, RL, Nakajima ST, Santoro NF, Wysocki S. Managing the

Menopause. Contemporary Ob-Gyn 1999; 1-26.

125. Barbieri, RL. Should all women over 60, be screened for bone mineral density. Contemp Ob Gyn 1999; 44:83-88

126. Barbieri, RL. Ambulatory management of uterine leiomyomata. Clinical

Obstet Gynecol 1999; 42: 196-205.

127. Barbieri, RL. Fast track protocol for the diagnosis of endometriosis. J Gynecol Tech 1999, 5:161-2.

128. Goldman MB, Misner SA, Barbieri RL. Infertility. In Goldman MB, Hatch

ML, Eds. Women and Health. Academis Press 2000; pp 196-214.

129. Scialli A, Barbieri, RL, Olive D, Glasser MH, Winkel CA. Chronic pelvic pain: an integrated approach. Association of Professors of Gynecology and Obstetrics Educational Series on Women’s Health Issues. 2000; pp 1-52.

130. Barbieri RL. Expanding the role of physical examination in evaluating

chronic pelvic pain. OBG Management 2000; 12 (Suppl): 12-13.

131. Kim LH, Taylor AE, Barbieri RL. Insulin sensitizers and polycystic ovary syndrome: Can a diabetes medication treat infertility? Fertil Steril 2000; 73:1097-1098.

132. Barbieri RL, Domar AD, Loughlin KR. Six steps to increased fertility. An

integrated medical and mind/body program to promote conception. Simon Schuster, New York. 2000;pp1-246.

133. Barbieri RL. Gonadotropin-releasing hormone analogues for contraception.

Infertility and Reproductive Medicine Clinics of North America. 2000; 11: 715-728.

134. Barbieri RL. Approach to menstrual disorders and galactorrhea. In Humes

HD (ed) Kelley’s Textbook of Internal Medicine. Lippincott. Philadelphia. 2000; pp 2620-2623.

135. Barbieri RL. Approach to sexual dysfunction in the female. In Humes HD

(ed) Kelley’s Textbook of Internal Medicine. Lippincott. Philadelphia. 2000; pp 2631-2.

136. Barbieri RL. Disorders of the reproductive cycle in women. In Humes HD

(ed) Kelley’s Textbook of Internal Medicine. Lippincott. Philadelphia. 2000; pp 2740-2743.

Barbieri C.V. 62

Reviews (continued): 137. Barbieri RL. Evaluating pelvic pain using Barbieri’s triad. OBG

Management 2000; 12: 26-39. 138. Barbieri RL. Disorders of the uterus. In Precis: Gynecology. American

College of Obstetricians and Gynecologists. Washington, D.C. 2001; pp 73-81.

139. Barbieri RL, Berga, SL, Chang RJ, Santoro NF. Managing the

perimenopause. Association of Professors of Gynecology and Obstetrics. 2001; pp 1-18.

140. Barbieri RL, Repke JT. Medical disorders in pregnancy. In Braunwald EB,

Fauci AS, Kajper DL, Hauser SL, Longo DL, Jameson JL. (Eds.) Harrison’s Principles of Internal Medicine. McGraw-Hill, NY. 2001; pp 25-31.

141. Barbieri RL. Wine and women’s health: what the evidence shows. OBG

Management 2001; 13: 44-52.

142. Barbieri RL. Endometriosis. In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. 3rd Edition. Lippincott. Philadelphia. 2001; pp 972-976.

143. Barbieri RL, Hornstein MD. Clomiphene: 5 tactics to help make it work.

OBG Management 2001; 13: 62-72.

144. Barbieri RL. Managing patients with low trauma fractures. OBG Management 2001; 13:38-45.

145. Barbieri RL. Management of infertility caused by ovulatory dysfunction.

ACOG Practice Bulletin #34. Obstet Gynecol 2002; 99:347-58.

146. Barbieri RL. Endometriosis. Rakel RE, Bope ET, Eds. In Conn’s Current Therapy 2002. WB Sauders 2002. pp 1065-1070.

147. PROLOG Task Force for Patient Management in the Office. Barbieri RL,

Smith RP, Eds. PROLOG: Patient Management in the Office (4th Edition). American College of Obstetricians and Gynecologists. 2002. pp 1-215.

148. Barbieri RL, Lobo RA, Walsh BW, Santoro NF. Improving quality of life

during menopause. Association of Professors of Gynecology and Obstetrics. 2002. pp 1-21.

63

149. Barbieri RL, Missmer SA. Endometriosis and infertility: a cause-effect

relationship? In: Yoshinaga K, Parott EC. Endometriosis: emerging research and intervention strategies. Annals New York Academy of Sciences. Volume 955. 2002. pp 23-33.

150. Barbieri RL. Adrenal gland disorders. Precis. Reproductive Endocrinology,

American College of Obstetricians and Gynecologists. 2nd Edition, 2002. pp 105-113.

151. Lifford KL, Barbieri RL. Diagnosis and management of chronic pelvic pain.

Urol Clin N Am 2002; 29:637-647.

152. Barbieri RL. Endometriosis. In: Rake, Bope (Eds.) Conn’s Current Therapy 2003. Saunders. Philadelphia 2003.

153. Barbieri RL. New options in osteoporosis therapy: combination and

sequential treatment. OBG Management 2003; 15:60-67.

154. Barbieri RL. Amenorrhea. In: Dale DC, Federman DD. (Eds) Scientific American Medicine 2003 Edition. WebMD Professional Publishing, New York. pp. 947-954.

155. Barbieri RL. Polycystic ovary syndrome. In: Dale DC, Federman DD. (Eds)

Scientific American Medicine 2003 Edition. WebMD Professional Publishing, New York. pp. 962-972.

156. Repke JT, Barbieri RL. Medical problems in pregnancy. In: Dale DC,

Federman DD. (Eds) Scientific American Medicine 2003 Edition. WebMD Professional Publishing, New York. pp. 992-999.

157. Barbieri RL. Endometriosis. In: Dale DC, Federman DD. (Eds) Scientific

American Medicine 2003 Edition. WebMD Professional Publishing, New York. pp. 1000-1007.

158. Barbieri RL. Urinary incontinence and the over-active bladder. In: Dale DC,

Federman DD. (Eds) Scientific American Medicine 2003 Edition. WebMD Professional Publishing, New York. pp. 1008-1013.

159. Barbieri RL. Metformin for PCOS Symptoms: 5 Challenging Cases. OBG

Management 2003; 15:18-38.

160. Barbieri RL, Derman RJ, Gass MLS, Santoro NF, Smith RP. Current strategies for managing osteoporosis. Association of Professors of Gynecology and Obstetrics. 2003; pp. 1-18.

Barbieri C.V. 64

Reviews (continued): 161. Barbieri RL. Gonadotropin releasing hormone agonist and antagonist for

endometriosis. In Tulandi T, Redwine D. (Eds.) Endometriosis: Advances and Controversies. Marcel Dekker, NY 2004, pp. 219-244.

162. Barbieri RL. 18 Hirsutism ACP Medicine Online. Dale DC, Federman (Eds.)

NY 2004, pp. 1-7.

163. Barbieri RL. Osteoporosis. In: Precis. Primary and Preventive Care. American College of Obstetricians and Gynecologists. Washington, DC 2004, pp. 178-184.

164. Barbieri RL, Gargiulo AR. Metformin for the treatment of the polycystic

ovary syndrome. Minerva Ginecol 2004; 56: 63-79.

165. Barbieri RL, Repke JT. Medical disorders during pregnancy. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. (Eds.) Harrison’s Principles of Internal Medicine, McGraw-Hill NY 2004, pp. 32-38.

166. Barbieri RL. The Breast. In: Strauss JF, Barbieri RL. (Eds.) Yen and Jaffe’s

Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. 5th Edition. Elsevier Saunders, Philadelphia. 2004, pp. 307-326.

167. Barbieri RL. Female Infertility. In: Strauss JF, Barbieri RL. (Eds.) Yen and

Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. 5th Edition. Elsevier Saunders, Philadelphia. 2004, pp. 633-668.

168. Barbieri RL, Hornstein MD. Assisted Reproduction. In: Strauss JF, Barbieri

RL. (Eds.) Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. 5th Edition. Elsevier Saunders, Philadelphia. 2004, pp. 839-874.

169. Barbieri RL. Osteoporosis Update. OBG Management 2004; 16: 63-73.

170. Jain T, Barbieri RL Website quality assessment: Mistaking apples for

oranges. Fertil Steril 2005; 83:545-7.

171. Barbieri RL. A renaissance in reproductive endocrinology and infertility. Fertil Steril 2005; 84:576-7.

172. Barbieri RL. Bone loss in young women. OBG Management 2006; 18:51-61

173. Barbieri RL. Disorders of the uterus. In Precis Gynecology. American

College of Obstetricians and Gynecologists. Washington, DC. 2006, pp 95-102.

65

Reviews (continued): 174 Barbieri RL. Adrenal gland disorders. In Precis. Reproductive

Endocrinology. American College of Obstetricians and Gynecologists. Washington, DC. 2007, pp. 121-127

175. Barbieri RL. Clomiphene versus metformin for ovulation induction in

polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92:3399-3401

176. Barbieri RL, Kaunitz AM, Levy BS. Hormone therapy revisited. Update. American College of Obstetricians and Gynecologists 2007; 33:1-9.

177. Armstrong EJ, Barbieri RL. Pharmacology of reproduction. In Golan DE,

Tashjian AH, Armstrong EJ, Armstrong AW. (Eds.) Principles of pharmacology. 2nd Edition, Lippincott, Williams and Wilkins. Philadelphia 2008, pp509-528.

178. Barbieri RL, Repke JT. Medical disorders during pregnancy. In: Fauci AS,

Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson LJ, Loscalzo J. Harrison’s principles of internal medicine. McGraw-Hill. NY 2008, pp 44-8.

179. Barbieri RL. Enhancing our practice environment in order to support a long,

fulfilling and productive career. Obstet Gynecol 2008; 112:7-9. 180. Barbieri RL. Are you assessing risk and discussing new treatments for

osteoporosis. SRM. 2008; 6:8-11. 181. Barbieri RL. The Breast. In: Strauss JF, Barbieri RL (eds.) Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology and Clinical

Management. 6th Edition. Elsevier Saunders, Philadelphia. 2009, pp. 235-248.

182. Barbieri RL. Female Infertility. In: Strauss JF, Barbieri RL (eds.) Yen and

Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. 6th Edition. Elsevier Saunders, Philadelphia. 2009, pp. 517-546.

183. Barbieri RL. Osteoporosis. In Precis. Primary and Preventive Care.

American College of Obstetricians and Gynecologists. Washington DC. 2009, pp 171-176.

184. Barbieri RL, Repke JT. Medical disorders during pregnancy. In: Longo DL,

Fauci AS, Kasper DL, Hauser SL, Jameson JL. Loscalzo J. Harrison’s Principles of Internal Medicine. McGraw Hill NY, 2011, pp 55-61.

Barbieri C.V. 66

Reviews (cont.) 185. Armstrong EJ, Barbieri RL. Pharmacology of reproduction. In: Golan DE,

Tashjian AH, Armstrong EJ, Armstrong AW. (Eds) Principles of Pharmacology. 3rd Edition. Wolters Kluwer. Philadelphia 2012, pp 505-523.

186. Barbieri RL. Office gynecology in the internet age. Clinical Obstet Gynecol

2012; 55:596-604. 187. Barbieri RL, Kaunitz AM, Stunkel CA. Osteoporosis across a woman’s life

cycle. ACOG update 2012; 38:1-9. 188. Barbieri RL. Your age-based guide to comprehensive well-woman care.

OBG Management 2012; 24:20-33. 189. Missmer SA, Abusief ME, Barbieri RL, Goldman MB. Infertility. In:

Goldman MB, Troisi R, Rexrode KM. (Eds) Women and health. 2nd Edition. Elsevier. Amsterdam 2013, pp 251-270.

190. Archer DF, Autry A, Barbieri RL, et al. A statement on abortion by 100

professors of obstetrics: 40 years later. Published in Am J Obstet Gynecol 2013; 209: 193-9 and Contraception 2013 epub March 15.

191. Barbieri RL. The Breast. In: Strauss JF, Barbieri RL (eds.) Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology and Clinical

Management. 7th Edition. Elsevier Saunders, Philadelphia. 2014, pp. 236-242.

192. Barbieri RL. Female Infertility. In: Strauss JF, Barbieri RL (eds.) Yen and

Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. 7th Edition. Elsevier Saunders, Philadelphia. 2014, pp. 512-537.

193. Barbieri RL. The endocrinology of the menstrual cycle. In: Rosenwaks Z,

Wassarman PM. (eds.) Human Fertility: Methods and Protocols. Humana Press. N.Y. pp 145-170. Also cited as: Methods Mol Biol 2014; 1154: 145-169.

194. Barbieri RL. Hyperandrogenism. In: Curtis MG, Linares ST, Antoniewicz

L. (eds.) Glass’ Office Gynecology. 7th Edition. Wolters Kluwer Health. Philadelphia. 2014, pp. 39-52.

195. Barbieri RL. Polycystic Ovary Syndrome: diagnosis and management.

NEJM Journal Watch Women’s Health 2014; 19: 85-6.

67

196. Barbieri RL. Ovarian hyperstimulation syndrome. In Loriaux, DL, Endocrine

Emergencies: recognition and treatment. Human Press NY, 2014. pp 213-26. 197. Barbieri RL, Martin KA, Shifren JL. Menopause- an update. American

College of Obstetricians and Gynecologists Update series. 2015; 41: 1-9. 198. Barbieri RL, Repke JT. Medical disorders during pregnancy. In: Kasper DL, ,

Fauci AS, , Hauser SL, Longo DL Jameson JL, Loscalzo J. Harrison’s Principles of Internal Medicine. McGraw Hill NY, 2015, pp.

199. Barbieri RL (ed.) Modern Management of Fibroids. Clinical Obstetrics and Gynecology. 2016; 59: 1. 200. Barbieri RL. Intractable shoulder dystocia: a posterior axilla maneuver may save the day. OBG Management 2016; 28: 17,18,20,21. 201. Armstrong EJ, Barbieri RL. Pharmacology of reproduction. In: Golan De,

Armstrong EJ, Armstrong AW. (Eds) Principles of Pharmacology. 4th Edition. Wolters Kluwer. Philadelphia 2017, pp541-60.

Barbieri C.V. 68

Electronic Publishing

1. Barbieri RL. Editor-in-Chief. Obstetrics, Gynecology and Women’s Health. UpToDate, Wellesley, Massachusetts.

2. Taylor AE, Barbieri RL. Pathogenesis and causes of hirsutism. UpToDate, pp1-

4.

3. Taylor AE, Barbieri RL. Evaluation of women with hirsutism. UpToDate, pp 1-6.

4. Taylor AE, Barbieri RL. Treatment of hirsutism. UpToDate, pp 1-5.

5. Taylor AE, Barbieri RL. Diagnosis and treatment of polycystic ovary syndrome. UpToDate, pp 1-6.

5a. Barbieri RL, Ehrmann DA. Diagnosis and treatment of polycystic ovary syndrome. UpToDate, Ed 12.3, pp 1-6.

6. Barbieri RL. Primary dysmenorrhea. UpToDate, pp 1-8.

7. Barbieri RL. Chronic pelvic pain. UpToDate, pp 1-9.

8. Taylor AE, Barbieri RL. Clinical manifestations of polycystic ovary syndrome.

UpToDate pp 1-9.

8a. Barbieri RL, Ehrmann DA. Clinical manifestations of polycystic ovary syndrome. UpToDate, Ed 12.3, pp 1-9.

9. Barbieri RL. The initial fertility consultation in couples planning pregnancy.

UpToDate pp 1-12.

10. Barbieri RL. Edometriosis and infertility. UpToDate pp 1-11.

11. Barbieri RL, Hornstein MD. Strategies for improving the efficacy of clomiphene induction of ovulation. UpToDate pp 1-8.

12. Barbieri RL. Treatment of unexplained infertility. UpToDate pp 1-9.

13. Taylor AE, Barbieri RL. Causes of and diagnostic approach to primary

amenorrhea. UpToDate pp 1-12.

14. Barbieri RL. Amenorrhea. In: Scientific American Medicine. WEBMD, New York.

69

Electronic Publishing (cont.) 15. Barbieri RL. Polycystic Ovary Syndrome. In: Scientific American Medicine.

WEBMD, New York.

16. Barbieri RL. Urinary incontinence and the overactive bladder. In: Scientific American Medicine. WEBMD, New York.

17. Barbieri RL. Endometriosis. In: Scientific American Medicine. WEBMD, New

York.

18. Martin KA, Rosen HN, Barbieri RL. Estrogen replacement therapy: benefits and risks. UpToDate, pp. 1-17.

19. Martin KA, Rosen HN, Barbieri RL. Recommendations for estrogen

replacement therapy. UpToDate, pp. 1-9.

20. Repke JT, Barbieri RL. Medical problems in pregnancy. In: Scientific American Medicine. WEBMD, New York.

21. Martin KA, Rosen HN, Barbieri RL. Estrogen replacement therapy: benefits and

risks. UpToDate, Ed 11.1, Wellesley, MA, pp. 1-17.

22. Martin KA, Rosen HN, Barbieri RL. Hormone preparations for estrogen replacement therapy. UpToDate, Ed 11.1, Wellesley, MA, pp. 1-13.

23. Martin KA, Rosen HN, Barbieri RL. Recommendations for estrogen

replacement therapy. UpToDate, Ed 11.1, Wellesley, MA, pp. 1-10.

24. Martin KA, Barbieri RL. Postcoital contraception. UpToDate, Ed 11.2, Wellesley, MA, pp. 1-5.

24.Barbieri RL. Emergency Contraception. UpToDate, Ed 12.3, Wellesley MA, pp 1-5

25. Barbieri RL. Metformin for treatment of the polycystic ovary syndrome.

UpToDate, Ed 11.2, Wellesley, MA, pp. 1-15.

26. Barbieri RL. Gonadotropin releasing hormone agonists for long-term treatment of endometriosis. UpToDate, Ed 11.2, Wellesley, MA, pp. 1-10.

27. Taylor AE, Barbieri RL. Causes and diagnostic approach to secondary

amenorrhea. UpToDate, Ed 11.2, Wellesley, MA, pp. 1-12. 28. Martin KA, Barbieri RL. Overview of contraception. UpToDate, Ed 11.2,

Wellesley, MA, pp. 1-16.

Barbieri C.V. 70

Electronic Publishing (continued):

29. Martin KA, Barbieri RL. Overview of the use of oral contraceptives. UpToDate, Ed. 12.3, Wellesley, MA, pp. 1-10.

30. Barbieri RL. How to fit and use a diaphragm for contraception. UpToDate, Ed

12.3, Wellesley, MA, pp. 1-8.

31. Kushung W, Barbieri RL. Etiology and evaluation of female infertility. UpToDate, Ed 12.3, Wellesley MA, pp 1-18.

32. Kushung W, Barbieri RL. Overview of treatment of female infertility.

UpToDate, Ed 13.1, Wellesley MA, pp 1-12.

33. Barbieri RL. Steroid hormone metabolism in the polycystic ovary syndrome. UpToDate, Ed 13.2, Wellesley MA, pp 1-8.

71

Editorials 1. Barbieri RL. Putting a premium on the process. OBG Management. 2000; 12:13. 2. Barbieri RL. Anchoring our practice on the evidence. OBG Management. 2000;

12:10-12.

3. Barbieri RL. Preserving lives through safety science. OBG Management. 2000; 12:8-11.

4. Barbieri RL. Time, reimbursement and coding inequities. OBG Management.

2000; 12:8-11.

5. Barbieri RL, Gardner Roxanne. Equitable insurance coverage for contraceptives. OBG Management. 2000; 12:8-9.

6. Barbieri RL. A time to renew our spirits with a gift from the heart. OBG

Management. 2000; 12:8.

7. Barbieri RL, Rodriguez-Thompson D. Reducing tobacco use: a new year’s resolution. OBG Management. 2001; 13:8-13.

8. Barbieri RL. Practicing medicine at the speed of light. OBG Management. 2001;

13:8-10.

9. Barbieri RL, Lifford K. Resident work hours a delicate balance. OBG Management. 2001; 13:8-13.

10. Barbieri RL. The role of diet and lifestyle in fighting heart disease. OBG

Management 2001; 13:8-10.

11. Barbieri RL. The role of mammography and clinical breast examination. OBG Management 2001; 13:8.

12. Barbieri RL. What we can learn from craft guilds. OBG Management 2001; 13:

6.

13. Barbieri RL. Colorectal cancer screening: examine the entire organ. OBG Management 2001; 13: 8.

14. Barbieri RL. Drowning in a sea of paperwork. OBG Management 2001; 13: 8.

15. Barbieri RL. Knowledge in cyberspace: a challenge and an opportunity. OBG

Management 2001; 13:8,13.

Barbieri C.V. 72

Editorials (continued):

16. Barbieri RL. Is the nursing shortage a symptom of larger ills? OBG Management 2001; 13:10,12.

17. Barbieri RL. Addressing a patient’s chasm of grief. OBG Management 2001;

13:8,13.

18. Barbieri RL. As the year turns, a new focus on healthy eating. OBG Management 2002; 14:8.

19. Camann WR, Barbieri RL. A pivotal partnership: obstetrics and anesthesiology.

OBG Management 2002; 14:8.

20. Barbieri RL. Continuing in Hippocrates footsteps. OBG Management 2002; 14:6.

21. Barbieri RL. Flexible work hours: the next frontier. OBG Management 2002;

14:6.

22. Barbieri RL. Why malpractice has got to go. OBG Management 2002; 14:8.

23. Barbieri RL. Are the clinical guidelines you use obsolete? OBG Management 2002; 14:9.

24. Barbieri RL. Managing the fallout from the women’s health initiative. OBG

Management 2002; 14:10.

25. Barbieri RL. Making short shift of long shifts: the regulation of resident work hours. OBG Management 2002; 14:8.

26. Barbieri RL. Managing the medical liability riddle. OBG Management 2002;

14:6.

27. Barbieri RL. In the patient’s interest: the PhRMA code. OBG Management 2003; 15:10.

28. Barbieri RL. Warning: the estrogen product you are about to prescribe…OBG

Management 2003; 15:8.

29. Barbieri RL. Physician walkouts and the fraying of the social contract. OBG Management 2003; 15:8.

30. Barbieri RL. Thou shalt not bear false witness. OBG Management 2003; 15:8.

73

Editorials (continued): 31. Barbieri RL. Another high stakes examination for physicians. OBG

Management 2003; 15:8.

32. Barbieri RL. New advances-and challenges-in cervical cancer screening. OBG Management 2003; 15:8-13

33. Barbieri RL. HIPAA: the good, the bad and the ugly. OBG Management 2003:

15: 8-12.

34. Barbieri RL. What is really at stake, in the jackpot liability game? OBG Management 2003; 15: 8-11.

35. Barbieri RL. Latest data on hormone replacement therapy side effects: further

reinforcement, some reassurance. OBG Management 2003; 15: 8-9.

36. Barbieri RL. Exploding health care costs threaten other vital needs. OBG Management 2003; 15: 8-11.

37. Barbieri RL. Universal health coverage: Maine braves a new world. OBG

Management 2003; 15: 8-9.

38. Barbieri RL. Hormone therapy: for the right patients, benefits outweigh risks. OBG Management 2003; 15:8, 13.

39. Barbieri, RL. Low reimbursement and excessive liability results in long waits

for mammography. OBG Management 2004; 16:8.

40. Barbieri RL. Unique hormone regimens, unique clinical effects. OBG Management 2004; 16:8-9.

41. Barbieri RL. Overgeneralizing WHI: What are they thinking? OBG

Management 2004; 16:8.

42. Barbieri RL. California dreaming: who will save the uninsured? OBG Management 2004; 16: 8.

43. Barbieri RL. Sometimes a vote of 23 to 4 is a tie. OBG Management 2004; 16:8,

10.

44. Barbieri RL. A difficult beginning: starting out with disabling student debt. OBG Management 2004; 16:8,10.

45. Barbieri RL. It is time to target a new cesarean delivery rate. OBG Management

2004; 16:10-11.

Barbieri C.V. 74

Editorials (continued) 46. Barbieri RL. How John Edwards changed case law and multiplied liability.

OBG Management 2004; 16:8,10.

47. Barbieri RL. The easy road. OBG Management 2004; 16:8-10.

48. Barbieri RL. Three strikes and you are out of a job. OBG Management 2005; 17:12.

49. Barbieri RL. True grit: A tale of Texas tort reform. OBG Management 2005;

17:11.

50. Barbieri RL. Nevada voters bring back sunny skies. OBG Management 2005; 17:12.

51. Barbieri RL. Check the fine print in Emtala’s proliferating regulations. OBG

Management 2005; 17:10.

52. Barbieri RL, The few, the proud, the obs. OBG Management 2005; 17:12.

53. Barbieri RL. Too many embryos for one woman. OBG Management 2005: 17:8,10.

54. Barbieri RL. Testosterone patch: The road not taken. OBG Management 2005;

17:9-10.

55. Barbieri RL. Repeat Caesarean: Again and again and again. OBG Management 2005; 17:8,10.

56. Barbieri RL. Decline of clomiphene for PCOS-related infertility. OBG

Management 2005; 17:12.14.

57. Barbieri RL. Does male circumcision cut the risk of HIV infection. OBG Management 2005; 17:9,10.

58. Barbieri RL. Massive obstetric hemorrhage: High- and low-tech tools. OBG

Management 2005; 17:9,10.

59. Barbieri RL. The pipeline runneth over. OBG Management 2005; 18:10.

60. Barbieri RL. Minimally invasive hysterectomy: We are at a tipping point. OBG Management 2005; 18:10,14.

61. Barbieri RL. A life-extending advance in the treatment of ovarian cancer. OBG

Management 2005; 18:8,11.

75

Editorials (continued): 62. Barbieri RL. How many days does it take you to pay your liability insurance? OBG Management 2006; 18:10,14. 63. Barbieri RL. Estrogen treatment: Safe and effective in early menopause. OBG Management 2006; 18:10,13. 64. Barbieri RL. A new option for chemoprevention of invasive breast cancer.

OBG Management 2006; 18:10,14,16.

65. Barbieri RL. Crash cesarean section: What is your decision-to-delivery time? OBG Management 2006; 18:10,13.

66. Barbieri RL. Can we insure “justice for all” in medical injury cases? OBG Management 2006; 18:9,13. 67. Barbieri RL. It’s time to restrict the use of episiotomy. OBG Management 2006; 18:8,12. 68. Barbieri RL. It’s been a long voyage for Plan B, but patience and persistence won. OBG Management 2006; 18:10,12 69. Barbieri RL. Is Premarin actually a SERM? OBG Management 2006; 18:10,13 70. Barbieri RL. Let’s get serious about the metabolic syndrome. OBG Management 2006; 18:10,13. 71. Barbieri RL. Is the end of an era here for magnesium sulfate tocolysis? OBG Management 2007; 19:6,9-10.

72. Barbieri RL. Activated factor VII proves to be a lifesaver in postpartum hemorrhage. OBG Management 2007; 19:8,12,15.

73. Barbieri RL. News about serous ovarian cancer. To our surprise it can begin in the fallopian tube. OBG Management 2007; 19:6,10.

74. Barbieri RL. We should encourage more women to use the modern IUD. OBG Management 2007; 19:10,14,16.

75. Barbieri RL. Give a uterotonic routinely during the third stage of labor. OBG Management 2007; 19:6,9,13. 76. Barbieri RL. A new long-term progestin has arrived. OBG Management 2007; 19:10,14,16.

Barbieri C.V. 76

Editorials (continued): 77. Barbieri RL. Lessons from Iraq reach the U.S. labor and delivery suite. OBG Management 2007; 19:8,12,16. 78. Barbieri RL. Don’t screen for ovarian cancer, but do pursue early detection. OBG Management 2007; 19:8,1,16. 79. Barbieri RL. Will the laborists, nocturnalists and weekendists preserve the rewards of obstetrics practice? OBG Management 2007; 19:8,12. 80. Barbieri RL. Troubling news: Maternal mortality is on the rise. OBG Management 2007; 19:10,13,14. 81. Barbieri RL. Fatigue: It is a fickle member of the obstetrical team. OBG

Management 2007; 19:10,12,15. 82. Barbieri RL. Do we gain when we “fully and openly” disclose our errors? OBG Management 2008; 20: 8,12,16,19. 83. Barbieri RL. Maintaining our cool with maintenance of certification. OBG

Management 2008; 20: 8,11,12. 84. Barbieri RL. She’s hypercaffeinated and she’s planning to conceive. OBG

Management 2008; 20: 8,11,15. 85. Barbieri RL. Consider bariatric surgery first for severely obese women. OBG Management 2008; 20: 9,14,16. 86. Barbieri RL. Should women attempt home birth after cesarean section? OBG Management 2008; 20: 8, 10, 13. 87. Barbieri RL. How will we know when we’ve got the right cesarean rate? OBG Management 2008; 20: 10, 13, 15. 88. Barbieri RL. Welcome to the tipping point in oral contraception prescribing.

OBG Management 2008; 20: 6, 8, 11. 89. Barbieri RL. More data on hormone therapy risks arrive to reshape practice. OBG Management 2008; 20: 10, 13, 14. 90. Barbieri RL, Day JJ. Reader, it’s all about you, and your patients. OBG

Management 2008; 20: 10, 12.

77

Editorials (continued): 91. Barbieri RL. Guidelines on fetal monitoring aim to codify normal, abnormal

FHR. OBG Management 2008; 20: 10, 12, 15. 92. Barbieri RL. The hospital has a new dress code for its vectors, er, doctors. OBG

Management 2008; 20: 6, 7. 93. Barbieri RL. 2 AM and obgfindit.com is on the job with you. OBG Management

2008; 20: 10, 13, 14. 94. Barbieri RL. Present at the birth of the 16-hour work shift. OBG Management

2009; 21: 8, 10, 14. 95. Barbieri RL. You should add the Bakri balloon to your treatments for OB

bleeds. OBG Management 2009; 21: 6, 7, 10. 96. Barbieri RL. Is this tool the cure for wrong-site surgery and other OR errors?

OBG Management 2009; 21: 6, 8, 10. 97. Barbieri RL. Recommendations for perinatal care have a troubling pedigree.

OBG Management 2009; 21: 8,10, 11. 98. Barbieri RL. Circumcision impedes viral disease. Will opposition fade? OBG

Management 2009; 21:6,8. 99. Barbieri RL. Health care: A Gordian knot of cost and access fazes reform. OBG

Management 2009; 21: 7, 8, 10. 100. Barbieri RL. We must take the lead in the battle against breast cancer. OBG

Management 2009; 20: 6, 8, 11. 101. Barbieri RL. Planning reduces the risk of maternal death. This tool helps. OBG

Management 2009; 21: 8, 10. 102. Barbieri RL. 7, 300+ days of remarkable change in your profession and your

practice. OBG Management 2009; 21:8, 10, 14. 103. Barbieri RL. The HPV vaccine is effective and safe, and it is vital. OBG

Management 2009; 21:6, 7, 11. 104. Barbieri RL. As uses widen for intrauterine contraception, why haven’t ob-

gyns become advocates? OBG Management 2009; 21:9, 10, 11. 105. Barbieri RL. Access to screening mammography: priceless. OBG Management

2010; 22:8, 11, 12.

Barbieri C.V. 78

Editorials (continued): 106. Barbieri RL. Stillbirth: Preventable tragedy or a lethal “act of nature”? OBG

Management 2010; 22:6, 8, 16. 107. Barbieri RL. Give vasopressin to reduce bleeding in gynecologic surgery. OBG

Management 2010; 22:1, 14, 15. 108. Barbieri RL. In women who have a pelvic mass, have you tried this new

ovarian cancer biomarker? OBG Management 2010; 22:8, 10, 12. 109. Barbieri RL. Consensus panel proposes new diagnostic criteria for gestational

diabetes. OBG Management 2010; 22:4, 6, 8. 110. Barbieri RL. How did we arrive at a world-wide epidemic of vitamin D

deficiency? Barbieri RL OBG Management 2010; 22: 8, 10, 11. 111. Barbieri RL. Permanent contraception provides a lesson in cost-effective

medicine. OBG Management 2010; 22:6, 8, 9, 10. 112. Barbieri RL. In the news, now on the shelf: a novel estradiol-based OCP.

OBG Management 2010; 22:6, 10, 11. 113. Barbieri RL. A new to the US first-line agent for heavy menstrual bleeding.

OBG Management 2010; 22:9, 10, 12. 114.Barbieri RL. Therapeutic hypothermia for newborns who suffer hypoxic-

ischemic birth injury. OBG Management 2010; 22:8, 12, 13. 115. Barbieri RL. The ubiquitous, drawn-out, annoying wait to see the doctor. OBG

Management 2010; 22:6, 8, 9. 116. Barbieri RL. Consider denosumab for postmenopausal osteoporosis. OBG

Management 2011; 23:8, 12, 13. 117. Barbieri RL. What can “meaningful use” of an EHR mean for your bottom line?

OBG Management 2011; 23:8, 10, 11, 12. 118. Barbieri RL. Levonorgestrel or Ulipristol: is one a better emergency

contraceptive than the other? OBG Management 2011; 23:8, 10, 11. 119. Barbieri RL. Stop staring at that Category II fetal heart-rate tracing and do

something to improve fetal status. OBG Management 2011; 23:6, 8, 9. 120. Barbieri RL. Big step forward and downward: an OC with 10 ug of estrogen.

OBG Management 2011; 23:8, 10, 12.

79

Editorials (continued): 121. Barbieri RL. OB and neonatal medicine practices are evolving in ways that

might surprise you. OBG Management 2011; 23:8, 10, 11. 122. Barbieri RL. Have you made the best use of the Bakri balloon in PPH. OBG

Management 2011; 23:6, 8, 9. 123. Barbieri RL. Not all contraceptives are suitable postpartum. OBG Management

2011: 23:8, 10, 11. 124. Barbieri RL. Medicare and Medicaid are on the brink of insolvency and you’re

not just a bystander. OBG Management 2011; 23: 8, 10-12. 125. Barbieri RL. Insomnia is a troubling and under-treated problem. OBG

Management 2011; 23:6, 8, 9. 126. Barbieri RL. How to repair bladder injury at the time of cesarean delivery. OBG

Management 2011: 23: 6, 8, 9. 127. Barbieri RL. Difficult fetal extraction at cesarean delivery. What should you

do? OBG Management 2012; 24:8, 9, 12. 128. Barbieri RL. Have you tried a progestin for your patient’s pelvic pain? OBG

Management 2012; 24:6, 8, 9. 129. Barbieri RL. Act fast when confronted by a coagulopathy postpartum. OBG

Management 2012; 24:8, 10, 11. 130. Barbieri RL. Stop performing median episiotomy! OBG Management 2012;

24:6, 8, 10, 11. 131. Barbieri RL. Try adding dexamethasone to your clomiphene infertility

regimen. OBG Management 2012; 24:10, 12, 13. 132. Barbieri RL. Be active, not passive, with how you screen for type 2 diabetes. OBG Management 2012; 24:6, 8, 9. 133. Barbieri RL. Routine use of oxytocin at birth: just the right amount to prevent postpartum hemorrhage. OBG Management 2012; 24:8, 10, 11. 134. Barbieri RL. Let’s increase our use of IUDs and improve contraceptive effectiveness in this country. OBG Management 2012; 24:5, 6, 8.

Barbieri C.V. 80

135. Barbieri RL. Let’s increase our use of implants and DMPA and improve contraceptive effectiveness in this country. OBG Management 2012; 24:8, 10, 11, 14.

136. Barbieri RL. A stitch in time: the B-Lynch, Hayman and Pereira uterine

compression sutures. OBG Management 2012; 6, 8, 10, 11. 137. Barbieri RL. 25 years in service to you our readers. OBG Management 2013;

25: 10, 12, 13. 138. Barbieri RL. The natural history of obstetric brachial plexus injury. OBG

Management 2013; 25: 8-10, 12. 139. Camann W, Barbieri RL. Mother-, baby- and family-centered cesarean

delivery: it is possible. OBG Management 2013; 25: 10, 12, 15. 140. Barbieri RL. You are the second responder to a shoulder dystocia emergency.

What do you do first? OBG Management 2013; 25: 10, 12, 15. 141. Barbieri RL. When estrogen isn’t an option, here is how I treat menopausal

symptoms. OBG Management 2013; 25: 9, 10, 12. 142. Barbieri RL. Successful treatment of chronic vaginitis. OBG Management 2013;

25: 10, 12. 143. Barbieri RL. Develop and use a checklist for 3rd- and 4th-degree perineal

lacerations. OBG Management 2013; 25: 8, 10, 12. 144. Barbieri RL. What is the gynecologist’s role in the care of BRCA previvors? OBG Management 2013; 25: 10-12, 14. 145. Barbieri RL. Should you start prescribing lorcaserin or orlistat to your

overweight or obese patients. OBG Management 2013; 25: 8, 11,12. 146. Barbieri RL. Osteoporosis treatment and breast cancer prevention: two goals,

one recommendation? OBG Management 2013; 25: 10, 13, 14. 147. Barbieri RL. 21st Century norms for assessing the progress of labor. OBG

Management 2013; 25: 12, 15. 148. Barbieri RL, Clarke RM. Ovarian teratoma (dermoid cyst) and encephalitis: a

link to keep on your radar. OBG Management 2014; 26:12, 15, 16. 149. Barbieri RL. Benefits and pitfalls of open power morcellation of uterine

fibroids. OBG Management 2014; 26: 10-12, 15.

81

150. Barbieri, RL. Options for reducing the use of open power morcellation of

uterine tumors. OBG Management 2014; 26: 10, 11, 20. 151. Barbieri RL. Following cesarean delivery, what is the optimal oxytocin infusion

duration to prevent postpartum bleeding. OBG Management 2014; 26: 10, 13, 14, 16.

152. Barbieri, RL, Farber MK. Does your obstetric unit have a protocol for treating

amniotic fluid embolism? OBG Management 2014; 26: 8-10, 13,14. 153. Barbieri, RL. Hormone therapy for menopausal vasomotor symptoms. OBG

Management 2014; 26: 10, 13-15. 154. Barbieri RL. Transfer to the hospital for women planning a home birth: A

high-risk obstetrics problem. OBG Management 2014; 26: 10-13. 155. Barbieri RL. Farewell to indigo carmine. OBG Management 2014; 26: 8,9. 156. Barbieri RL. Tackle the challenging shoulder dystocia emergency by practicing

delivery of the posterior arm. OBG Management 2014; 26: 10, 12, 14. 157. Barbieri RL. Letrozole versus clomiphene for ovulation induction. OBG

Management 2014; 26: 8, 10, 11. 158. Barbieri RL. Nitrous oxide for labor pain. OBG Management 2014; 26: 10-12,

14. 159. Barbieri RL. Stop using the hCG discriminatory zone of 1,500 to 2,000 to guide

intervention during early pregnancy. OBG Management 2015; 27: 8-10, 12. 160. Barbieri RL. Optimal pharmacologic treatment of nausea and vomiting of

pregnancy. OBG Management 2015; 27: 8-10. 161. Barbieri RL. Hysterotomy incision and repair: many options, many personal

preferences. OBG Management 2015; 27: 6, 8, 10. 162. Barbieri RL. Uterus transplant: medical breakthrough or surgical folly? 2015;

27: 8, 10, 12. 163. Barbieri RL. Why is obstetrics and gynecology a popular career choice for

medical students? OBG Management 2015: 27: 6, 8. 164. Barbieri RL. Advances in protection against oncogenic human

papillomaviruses: the 9-valent vaccine. OBG Management 2015; 27: 6-8.

Barbieri C.V. 82

165. Barbieri RL. Why is breast density a weighty matter. OBG Management 2015;

27: 7-11. 166. Barbieri RL. Let’s get organized to reduce maternal mortality. OBG

Management 2015; 27; 8-10. 167. Barbieri RL. Does hormone therapy reduce mortality in recently menopausal

women? OBG Management 2015; 27: 8, 10, 12. 168. Barbieri RL. Are you a champion of vaginal and laparoscopic hysterectomy?

OBG Management 2015; 27: 8,9,12. 169. Barbieri RL. Should newborns at 22 or 23 weeks’ gestational age be

aggressively resuscitated? OBG Management 2015; 27: 5-7. 170. Barbieri RL. Should you adopt the practice of vaginal cleansing with

povidone-iodine prior to cesarean delivery? OBG Management 2016; 28: 8, 10, 15.

171. Barbieri RL. Can we solve the problem of inadequate contraception for women

at high risk for adverse pregnancy outcomes? OBG Management 2016; 28: 8, 10, 11.

172. Barbieri RL. Start offering aspirin to pregnant women at high risk for

preeclampsia. OBG Management 2016; 28: 8, 10, 12. 173. Barbieri RL. Stop using rectal misoprostol for the treatment of postpartum

hemorrhage caused by uterine atony. OBG Management 2016; 28: 9, 10, 12. 174. Barbieri RL. Protecting the newborn brain- the final frontier in obstetric and

neonatal care. OBG Management 2016; 28: 8, 10, 12, 16. 175. Barbieri RL. In which clinical situations can the use of the 52-mg

levonorgestrel-releasing IUD (Mirena) and the TCu380A copper-IUD (ParaGard) be extended? OBG Management 2016; 28: 8, 9, 13, 14.

176. Barbieri RL. Have you measured lactate in your sick obstetrics and gynecology

patients during the past year? OBG Management 2016; 28: 8,9, 14. 177. Barbieri RL. Do you utilize vasopressin in your difficult cesarean delivery

surgeries? OBG Management 2016; 28: 8,10,11. 178. Barbieri RL, Miranne JM. Management of wound complications following

obstetric anal sphincter injury (OASIS). OBG Management 2016; 28: 8, 9, 14, 16, 43.

83

179. Barbieri RL, Roe AH. Long-acting reversible contraceptives and acne in

adolescents. OBG Management 2017; 29: 6, 8, 10. 180. Barbieri RL. Women’s Preventive Services Initiative guidelines provide

consensus for practicing obgyns. OBG Management 2017; 29: 7-11.